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Abstract 
Several psychometric instruments can be used to measure state-dependent variations in 
anxiety, including the State-Trait Anxiety Inventory (STAI), the Profile Of Mood States 
(POMS), the Positive and Negative Affect Schedule (PANAS) and the Visual Analog 
Scales (VAS). Each of these instruments rests on specific theoretical assumptions about 
the construct of State Anxiety, and has been widely used for this purpose in different 
research domains. However, it remains difficult to determine what may be the 
specificities of these four instruments, when the goal is to measure transient state-
dependent variations in anxiety. In this work, we provide a systematic and comparative 
literature review of studies which have explored rapid fluctuations (i.e. test-retest 
intervals not exceeding 24 hours) in state anxiety by means of these specific instruments. 
Almost 200 studies were eventually included in our review. This comparative review 
confirms that, despite some disparities and specificities, each of these four instruments 
provides a reliable measure to capture rapid state-dependent variations in anxiety, 
although they have been used in non-overlapping research domains or experimental 
contexts. 
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1. State anxiety: construct and measures 
The compelling observation that specific unpleasant emotional conditions, characterized by 
short-lived feelings of tension or apprehension, are actually prone to fluctuations depending 
on external contingencies in the environment was first put forward by Cattell (1966; Cattell & 
Scheirer, 1958 & 1963) in the second half of the last century, when he proposed the 
distinction between state anxiety and a more stable personality trait (referred to as trait 
anxiety), the latter being related to the tendency to experience feelings of tension and 
worrisome thoughts. Since this pioneering work, although no consensus has been reached 
about the true nature of state anxiety as a psychological or physiological construct, this 
concept has been further elaborated and refined by Spielberger (1966 & 1976) at a theoretical 
level, and it has been implicated in a myriad of empirical studies that have helped delineate 
and better characterize the numerous psychological reactions to stressors in humans (e.g., 
Moser, Hajcak, & Simons, 2005; Amir, Weber, Beard, Taylor, & Bomyea, 2008; O'Brien, 
Terry, & Jimmieson, 2008), or the physiological activations of the nervous system triggered 
by external or internal emotional stimuli (e.g., Swartzman, Edelberg, & Kemman, 1990; 
Chua, Krams, Toni, Passingham, & Dolan, 1999; Carrillo et al., 2001; Lucas et al., 2006; de 
Rooij, Schene, Phillips, & Roseboom, 2010).  
Levels of trait anxiety are considered crucial for people‘s successful adaptation to the 
environment, and have been shown to influence a multitude of core psychological 
components, including well-being and mental health (e.g., Duncko, Makatsori, Fickova, 
Selco, & Jezova, 2006; Bruk-Lee, Khoury, Nixon, Goh, & Spector, 2009). Consequently, 
good instruments for measuring stable inter-individual differences in anxiety proneness, 
considered as a personality trait, have been developed in the affective sciences literature (e.g., 
Cattel & Scheirer, 1963; Spielberger, Gorsuch, & Lushene, 1970), with the underlying idea 
that such trait is long lasting and mostly stable across time and situations. At the same time, a 
4 
 
growing number of studies suggested that trait characteristics of anxiety not always 
accurately predicted psychological responses in specific situations (e.g., Andrykowski, Redd, 
& Hatfield, 1985; Andrykowski & Redd, 1987; Perry, Parker, White, & Clifford, 1994), nor 
did they always show a straightforward relationship with the magnitude of anxiety 
fluctuations over time in response to external events (see Spielberger, 1983; Caumo et al., 
2000). In these cases, a less stable measure of anxiety, able to capture these short-lived 
variations in the state of the individual would be desirable.  
In order to appropriately meet these theoretical and empirical considerations, several 
instruments have been developed over the years, providing alternative instruments for 
measuring state-dependent fluctuations in anxiety, or more broadly, in affect or mood. 
Among these instruments, four self-report measures have been widely used in the affective 
sciences literature: the State-Trait Anxiety Inventory (STAI, Spielberger et al, 1970); the 
Profile Of Mood States (POMS, McNair, Lorr, & Droppleman, 1971); the Positive and 
Negative affect Schedule (PANAS, Watson et al., 1988), and various Visual Analog Scales 
(VAS), among which the Visual Analog Mood Scales (VAMS, Stern, Arruda, Hooper, 
Wolfner, & Morey, 1997) and the VAS-Anxiety (VAS-A). The aim of our review is to 
introduce and compare these four dominant measures as they have commonly been used in 
the literature across various domains and disciplines.  
1.1. Goals of the study 
As it will become evident from the specific sections concerning each of the aforementioned 
measures (see here below), they are all characterized by good psychometric properties. More 
specifically, they all provide rather sensitive estimates of fluctuations in anxiety. Capitalizing 
on their validity and flexibility of application, their use has rapidly led to the development of 
many research lines, resulting in an almost countless number of scientific publications 
available today. Accordingly, an attempt to provide a clear overview of their different fields 
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of application has become increasingly difficult. Surprisingly, no explicit attempt has been 
done in this direction so far, and the unique resources summarizing the literature on self-
report measures of state anxiety remain the comprehensive bibliographies of the individual 
instruments (e.g., Spielberger, 1989, for the STAI, and McNair, Heuchert & Shilony, 2003, 
for the POMS). Moreover, systematically comparing the psychometric properties of each 
measure seems rather difficult, since they have to be retrieved from various and sometimes 
scattered sources, such as the manuals and a set of psychometric papers addressing different 
combinations of instruments, with sometimes a lack of consistency across analysis 
techniques, sample types and research domains (e.g., Chlan, 2004; Stern et al., 1997; Millar 
et al., 1995). Ideally, psychometric assessments of the four instruments in the same samples, 
with systematic variations of the contexts, would need to be carried out in such a way to 
obtain comparative information at the psychometric level. Alternatively, a meta-analysis 
comparing the four instruments as used in the existing literature might help to gain insight 
into their specificity and sensitivity within certain domains. However, to the best of our 
knowledge, no such attempt has been made or is available in the literature so far. Many 
practical and/or theoretical reasons may potentially explain this lack of systematic 
comparison of these four instruments. First, as our systematic review suggests, the number of 
contributions is overwhelming and their contents heterogeneous, such that any attempt to 
summarize and integrate concurrently all these individual contributions into, for example, a 
meta-analysis, remains extremely challenging. Second, another major problem arises, as these 
instruments have primarily been used in different fields or domains, which renders any 
systematic or statistical comparison across these instruments almost impossible. Finally, it 
must be emphasized that it remains highly challenging to directly compare the psychometric 
properties of these instruments, which are in essence very different from each other (e.g. 
whereas the VAS-A is a single-item scale, the POMS is composed of 65 mood 
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adjectives/items). Given these existing difficulties and limitations, the goal of our review is 
certainly not to carry out a systematic comparison of the psychometric properties of these 
four instruments. Before such a useful work can be initiated, a rough comparison of these 
four instruments, as well as their preferred domains of application, is first required. This is 
precisely the purpose of our systematic and descriptive review, whose potential value is thus 
to provide a first systematic attempt to acknowledge this inherent complexity, and propose a 
set of classification variables that may eventually help researchers and clinicians in their 
selection of an instrument (or combination of instruments) aimed at capturing state-dependent 
variations in anxiety. 
In sum, the goal of our review is threefold: (i) first, we provide brief and consistent 
descriptions for each of the four instruments, including a careful presentation of their 
individual psychometric properties in relation to state anxiety. (ii) Second, we review the 
available psychometric data looking at convergent or discriminant validity as they have been 
reported in the reviewed studies, keeping in mind that all possible comparisons across the 
four instruments have not been performed yet in the literature, and hence the strength of the 
conclusions remains limited. (iii) Finally, our goal is also to provide a clear and transparent 
reading structure of the existing literature addressing questions related to the state anxiety 
construct, as explored using diverse methodologies and across different domains. Such an 
effort is worthwhile, as it enables to make more explicit some of the common associations 
made between specific measures and specific sub-domains within the affective science 
literature. Accordingly, our review work should provide initial clarifications of the possible 
reasons explaining some of these strong and common associations. Moreover, we also 
provide some general guidelines for the use and application of these four different 
instruments, when they are used to capture state-dependent variations in anxiety. As a result, 
our systematic review might turn out to be valuable for many researchers interested in 
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capturing state-dependent fluctuations in anxiety, who are frequently confronted with 
difficulties when deciding which self-report measure might be the most relevant or 
appropriate to address a specific research question.  
1.2 Methods 
As we have already alluded to here above, the extant literature on state anxiety using the 
aforementioned four measures has become impressively vast and differentiated. Hence, in 
order to efficiently read transversally across this impressive amount of studies and find some 
unifying factors or variables, we adopted a standardized and quite restrictive ―data-driven‖ 
approach to perform our literature review. As a first introductory step, we thoroughly present 
the exact criteria taken up for selecting these specific self-report measures (and not other 
ones), along with the criteria adopted for either including or excluding single studies from the 
large pool of available scientific resources. Furthermore, we list and precisely define the 
descriptive classification criteria used for the hits retained in our review. 
1.2.1 General inclusion criteria for the existing self-rating instruments 
As it turns out, a large number of self-report measures are nowadays available in the literature 
to measure anxiety, both in clinical or healthy populations. However, only a subset of self-
rated instruments is actually relevant for assessing state-dependent changes in anxious 
responses, while the majority of the tools are mainly designed and used for measuring the 
more stable dimension of trait anxiety (for an overview of existing trait anxiety measures, see 
Elwood & Olatunji, in press). Among the instruments that allow repeated assessments of 
anxiety with short time frame instructions, the tools that were primarily included in our 
review were the ones most widely used in the literature, best characterized by very good to 
excellent psychometric properties, and usually applied for scientific research purposes, both 
in clinical and non-clinical samples. These tools include the State-Trait Anxiety Inventory 
(STAI), the Profile Of Mood States (POMS), the Positive and Negative Affect Schedule 
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(PANAS) and the Visual Analog Scales (VAS). Other self-report instruments often used in 
the literature to capture state-dependent changes in anxiety are the Hamilton Anxiety and 
Depression Scale-Anxiety (HAM-A; Hamilton, 1959), and the Hospital Anxiety and 
Depression Scale-A (HADS-A; Zigmond & Snaith, 1983). However, these two latter scales 
were excluded from our systematic review because they have been used almost exclusively in 
clinical settings. Other measures, such as diaries, although extremely useful in clinical and 
non clinical settings, have been considered not relevant for this review either, mainly because 
they are not commonly used for repeated assessments using short test-retest intervals. 
Moreover, additional instruments, such as the Subjective Units of Distress Scale (SUDS; 
Wolpe, 1958 & 1990), the Tension and Effort Stress Inventory (TESI; Svebak, Ursin, 
Endresen, Hjelmen, & Apter, 1991) or the Emotion Assessment Scale (EAS; Carlson et al., 
1989), have been considered as well, but given their limited dissemination, they were not 
included in our review
1
. The same restriction has been applied to the different questionnaires 
designed to assess very specific subtypes of anxiety (as opposed to state anxiety defined as a 
general/uniform construct), as the Smith Somatic Stress Symptoms Scale-State (SSSSS-S; 
Smith, 1990), the Competitive State Anxiety Inventory (CSAI-2; Martens, Vealey, & Burton, 
1990), the Job Anxiety Scale (JAS; Linden, Muschalla, & Olbrich, 2008), the Dental Anxiety 
Scale (DAS, Corah, 1969) or similar more specific instruments.  
1.2.2 Description of the search strategy and specific selection criteria entailed 
To perform our systematic literature review we used multiple and commonly available search 
engines, including PsychInfo (from 1970), PsychArticles (from 1970), and the databases of 
ISI Web of Knowledge (namely, Web of Science
®
, Inspec
®
 and Medline
®
 from 1975). More 
                                                          
1
 When compared to the four dominant self-report measures (STAI: 315 total hits; PANAS: 188; POMS: 196; 
VAS: 190), it becomes evident that the use of the SUDS (23 hits in Isi Web of Knowledge, 0 hits in PsychInfo 
and PsychArticles), EAS (0 hits in Isi Web of Knowledge, 5 hits in PsychInfo and PsychArticles) and the TESI 
(1 hit in Isi Web of Knowledge, 6 hits in PsychInfo and PsychArticles) remains limited.  
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precisely, we searched these databases (upper time limit was April 2010) for hits containing 
―state anxiety‖, when combined with the following expressions or keywords: ―STAI-S‖, 
―STAI-State‖, ―STAI Y-1‖, ―POMS‖, ―PANAS‖, ―VAS‖2. Subsequently, we further refined 
our search in Web of Knowledge to studies falling under the domains ―Psychology‖ and 
―Neurosciences‖. During a second stage, once the corresponding relevant contributions were 
all collected (i.e., 889 hits when collapsing across questionnaires and search engines), another 
restriction on the basis of the time frame used for the assessments was applied: we included 
in this review studies using the aforementioned self-report measures in the context of short-
term instructions (e.g., at the moment, in the past few minutes etc.), as opposed to trait-like 
instructions (e.g., in the past few weeks, or in general) since we aimed to study transient state-
dependent fluctuations in anxiety. Among them, we considered relevant for this review only 
studies carried out with repeated measures designs, in which two (or more) testing occasions 
were separated by short
3
 test-retest intervals. This systematic and narrow search of the 
literature resulted in a total pool of 197 studies using at least one (or sometimes a 
combination of) the self-report measures described here above (STAI, POMS, PANAS and 
VAS) and meeting all the aforementioned selection criteria. Among these 197 studies, 130 
used the STAI, 70 the VAS, 40 the POMS and 33 the PANAS, either in isolation or in 
combination with another measure. Eighty-three studies used multiple measures. Clearly, the 
strength of this search procedure is that this specific outcome can be easily replicated by an 
independent researcher, if a similar literature search is performed with the same selection 
criteria, and using the same standard databases. The full bibliographical details of the 
                                                          
2
 Note that for the STAI-S the use of multiple research keys was required to overcome many inconsistencies in 
the way this specific part of the inventory has been commonly referred to in the literature, while for the three 
other questionnaires, a more widely accepted consensus regarding the use of the acronyms was found. In 
general, we adhered to the standard acronym used by the developers of the scales and reported in the published 
manuals.  
3
 ‘Short‘ has been formally operationalized as within the 24 hours. Although more longitudinal studies are 
certainly equally valid from a scientific viewpoint, we wished to focus in this review on ―rapid‖ changes in 
anxiety and assess the ability of these four instruments to capture these fast and short-lived fluctuations.  
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references/hits (n = 197) retrieved using the aforementioned search keys and criteria is 
provided as supplementary material, and thoroughly summarized in Table 1. 
1.2.3. Classification variables 
As a final step, we examined all the retained studies, and, in order to organize them in 
meaningful categories, we and carried out a systematic descriptive classification according to 
a limited number of variables. Six main classification variables were used: ―construct”, 
“domain”, “population”, “manipulation”, “direction of the effect”, and “approach‖. Note 
that these variables have been selected after careful consideration of the extreme variability 
across the retained studies, because, in the authors‘ opinion, they are good descriptors for the 
results, enabling comparisons among them despite their large heterogeneity. We have to 
acknowledge that other classification variables may be possible or acceptable, and were 
indeed initially considered by the authors (e.g., number of assessments; syndrome subtype in 
clinical studies; presence of concurrent non self-report measures, and so forth). However, 
these alternative variables have subsequently been excluded because they did not allow the 
extraction of any extra relevant information that could be used to better organize the different 
contributions included in our review. Moreover, we must add that each variable does not 
necessarily match a clearly identified concept of a putative theoretical model. Instead, the 
classification variables entailed are mainly descriptive and are based on the need of 
structuring the result of the search in an objective way, though respecting as much as possible 
the standpoint and interpretation of the authors of the original contributions.  
Here below, we provide a list of the variables used in our review, with their corresponding 
labels and characteristics.  
Construct: “Anxiety”, “Affect”, “Mood”, “Stress”, “Distress” or “Fear”. This 
classification variable corresponds to the theoretical or empirical concept that the authors 
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referred to, when articulating the research question or expected results. In this respect, most 
of the papers classified with the label ―Anxiety” refer to a negative emotional state, 
characterized by a reaction of the organism (usually including changes in the body and the 
brain) to stressors, undermining the general well-being. Most of the studies did not provide 
any specific definition for anxiety when they referred to this construct; usually they simply 
reported the Spielberger‘s one (Spielberger, 1983). However, in a minority of cases, the 
authors were more specific in their definition, and they usually referred to anxiety as a 
physiological reaction to stress, mediated by subcortical circuits in the brain, involving 
emotional, behavioral, somatic and cognitive components (e.g., entry 145 in Table 1); this 
physiological reaction, in specific occasions (e.g., patients tested before undergoing surgery) 
might lead to increased responses to stressors. Obviously, this definition still remains 
relatively broad, and encompasses different aspects of anxiety. Nonetheless, in order to 
compare the 197 entries retained in our review, as well as to stick as much as possible to the 
specificities of the authors‘ concepts, which not always readily reflected the constructs which 
the single self-report measures were designed to measure, we had to include, besides 
―Anxiety‖, other labels reflecting state-dependent fluctuation in emotional response (i.e., 
―Mood‖, ―Affect‖, ―Stress‖, ―Distress‖ and ―Fear).  
Domain: “Treatment”, “Experimental”, or “Applied”. Under the label Treatment we 
categorized each manipulation that was designed by the authors in order to lower or down-
regulate anxiety levels. Examples of ―Treatment” manipulations are pharmacological trials 
with anxiolytic drugs, alternative therapies as massage or aromatherapy, cognitive techniques 
(such as attentional bias or interpretation trainings), or more physical-oriented approaches 
(such as controlled bouts of aerobic gymnastics). By comparison, ―Experimental” indicates 
that the manipulation was designed with the aim of inducing increases in anxiety levels either 
experimentally (with cognitive tasks, for example) or pharmacologically (with psychoactive 
12 
 
or stress-resilience depressor drugs)
4
. We sometimes encountered studies in which, although 
the test-retest design criterion was fulfilled, no specific manipulation was visibly 
implemented. Representative examples are studies tracking affect fluctuations of circadian 
rhythm in healthy volunteers, or studies modeling the temporal dynamics of anxiety 
fluctuations in athletes during competitions. They have been included as ―Applied”.  
Population: “Clinical” vs. “Non Clinical”. With the Clinical label, we included studies that 
involved patients belonging to different ―medical‖ groups, including cancer patients, anxiety 
spectrum disorder patients (Generalized Anxiety Disorder, Social Anxiety Disorder, Post 
Traumatic Stress Disorder, different phobias), depressed patients, psychiatric in- and 
outpatients, patients scheduled for elective surgery, or, more generally, any hospitalized 
patient under treatment or observation. Under the ―Non Clinical” classification, were 
grouped the studies involving healthy participants, including in the subclinical domain (e.g., 
Table 1, entries 137, 154 & 156).  
Manipulation: “Central”, “Peripheral” or “No Manipulation”. This fourth variable refers to 
the content or modalities of the actual experimental manipulation performed by the authors in 
their study. A manipulation was considered ―Peripheral” when it primarily targeted the body 
(or specific segments of the body), and used physical actions to directly intervene on it. 
Examples of studies meeting this criterion are all the ones involving treatments as massage or 
physical activities, but also the experimental ones involving manipulations of physical 
activity characteristics (for example, when acute bouts of gymnastics were manipulated in 
                                                          
4
 In specific cases, when an experimental design combined anxiety down-regulation (e.g., via drugs) with 
experimentally increased anxiety (by means of stress-inducing tasks, for example), the preferred label was 
―Treatment”, because the experimental induction of tension or stress was meant to be only functional to the 
testing of the regulatory factor. On the other hand, when the positive outcome of an experimental manipulation 
was not expected or hypothesized a priori, or when both the directions of the effect were tested (for example, 
when exploring the effect of positive and negative interpretive bias training onto subsequent neutral tasks), the 
―Experimental” label has been chosen consistently. 
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duration or intensity to model their effects on mood or affect, instead of being applied with 
the explicit aim to obtain a moderating effect on anxiety). With ―Central”, we included the 
studies capitalizing on cognitive processes for either up- or down-regulating state dependent 
levels of anxiety (such as the implementation of stressful tasks, exposure to threat stimuli, 
classical conditioning paradigms, attentional bias training and so forth). Noteworthy, 
common to all these tasks, is that the effect of the manipulation is assumed to be mediated by 
cognitive/central processes. As it turned out, we encountered special difficulties to ascribe 
one of these two labels to a group of studies where certain experimental manipulations were 
applied through one of the sensory modalities of the participants (e.g., music, bright light 
exposure, olfactory stimulations) or blindly taken in by the volunteers (as any medication in 
placebo controlled pharmacological trials), hence suggesting a bottom-up/peripheral action or 
way of delivery. In other words, in all these cases the participant was mainly a passive 
receiver of the experimental action, with no mediation of any conscious cognitive processes. 
Nonetheless, and crucially, all these experimental trials assumed that the treatment, or more 
generally, the manipulation used, actually targeted structures of the central nervous system. 
For this reason, we decided to ascribe to all the studies involving these types of manipulations 
the ―Central” classification label. Furthermore, in another group of studies (mainly the ones 
classified as ―Applied‖ following the variable ―Domain”, see here above) the authors did not 
use any manipulation in order to test their hypotheses, and accordingly, the label ―No 
Manipulation” was ascribed to them. 
Direction of the effect: ―Induction” vs. “Regulation”. This variable seeks to identify the 
direction of the effect evoked by the manipulation onto the levels of state anxiety, here coded 
on the basis of the expected results. Hence, a study aiming at showing a reduction of state 
anxiety after completing a given physical treatment (e.g., a sauna session), would be 
classified as ―Regulation”. When considering an opposite case, for example a study 
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purposefully designed to measure the effects of increasing levels of state anxiety on decision 
making, this study would be classified as ―Induction”. Note that a combined label 
―Induction/Regulation‖ is possible for studies exploring the modulatory effects of treatments 
onto experimentally induced states of heightened anxiety.  
Approach: “Descriptive” vs. “Causal”. This sixth variable refers to a binary classification. A 
study is considered ―Causal” if the manipulation used in the experiment was purposefully 
designed to change levels of state anxiety. In all the other cases, namely when the 
manipulations were implemented for other purposes, and the fluctuations in state anxiety 
were measured only as a side effect, the study was classified as ―Descriptive”. For example, a 
study testing the relationship between Acute Tryptophan Depletion (ATD) procedures and 
amygdala reactivity to emotional stimulation, when the self-rated anxiety measures were 
eventually used only to control for undesired side-effects of the amino acid drink onto levels 
of affect (see entry 40 in Table 1), receives this qualification. 
2. Self-report measures capturing state-dependent fluctuations in anxiety  
2.1 State-Trait Anxiety Inventory (STAI) 
2.1.1 General description, main use and psychometric properties  
The State-Trait Anxiety Inventory (STAI) is a widely used instrument, primarily designed to 
measure anxiety either when it corresponds to a relatively stable personality disposition, or 
when it refers to a transitory emotional state, prompted by external or internal stimuli 
(Spielberger et al., 1970; Spielberger, 1983). Given the scope and aims of this review, here 
we mainly focus on the latest revised edition of the STAI
5
 (Form Y) and, more specifically, 
                                                          
5
 Since scores on STAI Form Y (Spielberger, 1983; Vagg, Spielberger & O‘Hearn, 1980) and STAI Form X 
(Spielberger et al., 1970) are highly correlated (r correlation coefficients ranging from .96 to .97 in American 
students), the use of the unrevised form may, in some cases, be accepted. Nevertheless, the use of the Y version 
is highly recommended because of its more stable and replicable underlying factor structure, obtained after 
having identified and replaced some items providing only poor psychometric properties (Spielberger, 1983).  
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on its state part (STAI Form Y-1). Although a large number of names or abbreviations have 
been ascribed to this inventory, we will consistently refer to the State-Anxiety scale of the 
STAI (Form Y) as to the STAI-S. The STAI-S is a 20-item self-rating inventory composed of 
short verbal statements that participants have to rate using a 4 points Likert scale according to 
the subjective experienced intensity of each described feeling (1 = not at all,  4 = very much 
so). The standard instructions stress the importance to perform the ratings using the intensity 
of feelings at the moment of the assessment (right now, that is, at this moment)
6
.  
The factor structure of the STAI-S is characterized by two main dimensions (Anxiety-Present 
and Anxiety-Absent), which are each loaded by ten of the 20 items belonging to the inventory. 
The total score, obtained after summing up the scores obtained for the 20 single items, ranges 
from 20 to 80 points, with higher scores indicating higher anxiety levels. The scores for the 
10 items loading the Anxiety-Absent factor are reversed before the sum is computed. 
Normative data for various English-speaking populations (e.g., students, adults in different 
age groups, military recruits) are reported in the Manual for Form Y (Spielberger, 1983). 
Noteworthy, translated forms of the STAI are now available in more than 60 languages and 
dialects (Spielberger & Reheiser, 2009), and norms for the some of the translated versions are 
available in the literature. Moreover, guidelines for further linguistic adaptations are provided 
in the STAI (Form Y) Test Manual (Spielberger, 1983).  
Overall, the STAI-S provides excellent psychometric properties: the internal consistency 
measured using Cronbach‘s alpha coefficient, ranges from good to excellent across several 
populations (e.g., between .86 and .95 in Spielberger, 1983; .94 in Creamer, Foran, & Bell, 
1995). Noteworthy, alpha coefficients are typically higher for the STAI-S when state anxiety 
is assessed under conditions of psychological distress, due to the peculiar positively skewed 
                                                          
6
 Simple modifications of the instructions enable flexibility, and yield similar assessments based either on 
previous (and still recent) moments in time (e.g., during the last block of the task, or during the therapeutic 
session), or for a future or hypothetical situation (just before or during a very difficult exam, for example).  
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distribution of the STAI-S scores in relaxed situations, as compared to a more normal 
distribution under conditions of psychological stress (Spielberger, 1983; Spielberger & 
Reheiser, 2009). Further evidence for the good reliability of the STAI-S is provided by 
relatively high item-remainder correlations (median r range from .55 to .63 in several 
independent normative populations). At the same time, however, the stability of the STAI-S, 
as measured by test-retest correlations, is low (in the Manual‘s samples r = .34 - .62, 
depending on the population and on the test-retest interval). Nonetheless, it is worth 
mentioning that given the transitory nature of the anxiety state that the STAI-S seeks to 
capture, low test-retest coefficients are actually expected, and even desirable to some extent 
(Spielberger, 1983). All in all, the reliability of the STAI Form Y-1 is very good. The same 
conclusion holds for the validity of this inventory. Construct validity is supported by the 
sensitivity of the STAI-S scores to manipulations of psychological stress: S-Anxiety scores 
are systematically higher when the inventory is administered just before or after stress-
inducing contingencies, or with the instructions to imagine being in such cases, as compared 
to administration in relaxed conditions. Since the evidence for concurrent and discriminant 
validity provided in the Manual mainly refers to the Trait Form of the STAI X, it will not be 
reported here
7
 (for details, see Spielberger, 1983). More relevant for the purpose of this work 
is the notion that the STAI-S items cover a wide item-intensity specificity range (i.e., the 
items differ in their sensitivity to diverse degrees and types of stress): because certain 
statements provide better discriminations at low anxiety levels, while others are more 
sensitive to variations in higher levels of stress, the STAI-S can be used to measure state 
anxiety under broadly varying stress conditions. For this reason, the use of the entire scale for 
                                                          
7
 Since the STAI-S was developed chronologically before other instruments measuring state anxiety, this may 
explain why no concurrent validity scores are provided in the Manual. In turn, the STAI-S has been used as 
reference for the validation of other instruments: for this reason, the correlation coefficients with the POMS, 
PANAS and VAS are reported in the sections concerning their respective psychometric properties (paragraphs 
2.2.1, 2.3.1 and 2.4.1).  
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measurement of state anxiety is highly recommended (Spielberger,1983). However, when 
shorter testing protocols are desirable (for either practical or clinical reasons), pruned 
versions are possible and acceptable. In this case, the single item-remainder correlations 
reported in the Manual should be taken into account when selecting the most optimal items 
while at the same time, the different item-intensity specificities should be evaluated in 
relation to the purpose and setting of the test (Bonke, Smorenburg, Vanderent, & Spielberger, 
1987).  
2.1.2 Practical usage 
The STAI-S is a brief and simple self-rating instrument, characterized by items covering a 
broad item-intensity specificity range. This feature qualifies it as a good measure for state 
changes in anxiety in a variety of experimental manipulations, both in clinical as well as 
subclinical populations. It must be noted that the Y form of the STAI was purified from items 
related to depression, mania or elation more than anxiety, and this version is therefore 
preferable to the X form (Spielberger, 1983). 
An additional feature of this inventory is that it leaves out items reporting bodily correlates of 
anxious response (e.g. shaky, sweaty) in favor of more psychologically-based statements. As 
a result, this methodological choice leads to a less spurious measure of psychological states, 
as compared to other self-report measures (e.g., PANAS-X, which includes items as Shaky 
and Sleepy, see here below for detailed presentation). 
As a last remark, since the STAI-S is primarily aimed at capturing subtle state fluctuations in 
anxiety driven by internal or external stimuli, it is recommended to administer it always 
before the Trait scale (STAI-T) in order to avoid unwanted priming effects of certain 
emotional states (e.g., tension).  
2.1.3 Main domains of utilization  
18 
 
The STAI-S has been widely used for the assessment of state anxiety in response to various 
experimental manipulations in the context of psychological investigations. When reviewing 
the impressively large amount of studies using the STAI-S as outcome measure, it becomes 
rapidly obvious that the ease to administer this questionnaire, as well as the simple and 
straightforward scoring procedure, combined with the stability of the underlying 
psychological construct, have led many researchers to use this specific instrument. However, 
across these studies, a recurrent way of using this self-report measure is to administer it in 
combination with anxiety-inducing procedures, in order to assess the corresponding changes 
in levels of state anxiety. Diverse techniques or approaches have been developed for this 
purpose, among which cognitive and social stressors appear to be the most widely used. For 
example, a well validated procedure to successfully induce increases in state anxiety and 
mental stress is the Trier Social Stress Test (TSST, Kirschbaum, Pirke, & Hellhammer, 1993, 
see Table 1, entries 4, 5, 28, 33, 90, 92, 106, 109, 171 & 193). In prototypical studies using 
this paradigm, participants are usually kept blind to the real purpose of the experiment (i.e., 
their actual response or resistance to the stressor), and are asked to complete the STAI-S, 
usually when entering the laboratory at the very beginning of the experiment. After obtaining 
this baseline measure of state anxiety, the experimental manipulation is usually applied, 
either to a subgroup of participants or to the whole sample. After the targeted manipulation 
has been performed, participants are typically informed of a stressful speech assignment, and 
state anxiety is assessed again using the STAI-S at the end of the preparation phase (that is, 
when anticipatory anxiety has presumably had the time to ramp up). Finally, the STAI-S is 
usually administered a last time after the end of the public speech task. Besides the TSST, 
several other manipulations have been successfully used to induce increased levels of mental 
stress, both in clinical and subclinical populations, when these changes were primarily 
measured using the STAI-S. These manipulations include stressful cognitive tasks involving 
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mental calculations (entries 100, 123 & 130), highly complex Tangram puzzles (entry 147), 
or high speed word processing tasks (entry 128), sometimes used in combination with 
exposure paradigms, in which fearful or phobic volunteers are briefly confronted to their 
threat-related objects (as in entry 154). Levels of anxiety have also been manipulated in 
healthy participants by means of exposure to various neutral stimuli which were designed to 
induce increases in tension (entries 30, 58 & 136). Furthermore, in order to achieve 
modulations in state anxiety, mood induction procedures with pictures (entry 56), videos 
(entries 167 & 184) or virtual reality environments (entries 53, 67 & 102) have also been 
used in combination with the STAI-S as main outcome measure. The main reason or 
motivation to induce changes in state anxiety levels in these populations is either to study the 
psychophysiology of state anxiety (as in entries 123 & 130) or to measure the protective 
effects of treatments in interaction with ecological stressful situations (as in entries 100 & 
128). In this context, the high item-intensity specificity of the STAI makes it an extremely 
useful instrument, since it enables to capture subtle changes in anxiety, even when 
differences in baseline scores are reported, as in groups differing for their vulnerability to 
anxiety (see Bonke et al., 1987). 
Whereas the majority of studies reviewed in our work and employing the STAI-S as an 
outcome measure used paradigms designed to induce anxiety in various ways (see Table 1, 
“direction of the effect” variable), a subgroup of studies have used the exact same instrument 
with the aim to explore possible reductions (or absences of change) of levels of state anxiety, 
in particular in clinical populations of patients undergoing surgery or anesthesia. Among 
these studies, the most common anxiolytic treatment that has been tested so far when the 
STAI-S is the main outcome measure, is exposure to music before medical operation (Table 
1, entries 26, 36, 42 and 103). These studies demonstrated the high variability in the use of 
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the STAI-S, usually with good results, even in clinical settings where the administration time 
must usually be kept as short as possible and the patient‘s burden limited.  
2.2 Profile of Mood States (POMS) 
2.2.1 General description, main use and psychometric properties 
The Profile Of Mood States (POMS) consists of a list of 65 adjectives (e.g., Friendly, Tense) 
describing possible moods or feelings, each to be scored on a 5 points scale (0 = Not at all; 4 
= Extremely) based on its compatibility with the participant‘s emotional state. Although 
judgments based on the feeling experienced in the past week (including the day of the test) 
are considered standard instructions of the POMS, more short-term requests (i.e., how are 
you feeling right now) can be used when investigating fluctuations of mood in relation to 
situational factors. Evidence was provided for independency of the POMS factor structure 
from the rating time frame (McNair et al., 1971, Appendix III). However, some caution is 
needed when comparing scores obtained using different temporal instructions to the general 
POMS norms provided in the Manual (McNair, Lorr, & Droppleman, 1992). Various studies 
comparing right now and past week instructions reported inconsistent patterns of differences 
in all the factor scores for the two instruction sets, therefore it has been suggested that the 
sensitivity of the single items might be affected by the different temporal frames in certain 
samples (for details, see McNair & Heuchert, 2005).  
Six independent studies addressed the factor structure of the POMS during the development 
phase of the questionnaire construction (see McNair et al., 1971): they all yielded to a 
number of factors comprised between 5 and 7, with the most stable dimensions being 
Tension-Anxiety, Depression-Dejection, Anger-Hostility, Vigor-Activity and Fatigue-Inertia. 
An independent replication further confirmed the stability of the three subscales of Anger-
Hostility, Vigor-Activity and Fatigue-Inertia, with less consensus for the Tension-Anxiety 
and Depression-Dejection dimensions, which were nonetheless detected in the two 
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experimental samples (Norcross, Guadagnoli, & Prochaska, 1984)
8
. The factors scores 
(obtained by adding up the single items scores within each sub-scale) can also be combined, 
with the Vigor score weighted negatively, in a Total Mood Disturbance Score (TMDS): the 
TMDS is presumed to be highly reliable because of high intercorrelations among the 
subscales (in particular in clinical populations), and it has even been proposed as a reliable 
measure of state anxiety because of its high correlation coefficients with the S-Anxiety scores 
of the STAI Y Form (Bolmont & Abraini, 2001), at least under conditions of psychophysical 
stress. These results suggest that the TMDS may actually reflect a complex low mood pattern that 
could partially overlap with the construct of state-anxiety response, as captured by the STAI-S. 
Nonetheless, the psychometric properties of the POMS have always been reported separately 
for the five (or six) factors, and this approach will also be followed here. Furthermore, 
because of the specific purpose of this review work on fluctuations in levels of state anxiety, 
the attention will be primarily focused on the Tension-Anxiety dimension of the 
questionnaire.  
Internal consistency of the Tension-Anxiety subscale is adequately high (Cronbach‘s alpha 
coefficients range between .90 and .92 in clinical populations, McNair & Heuchert, 2005). As 
was the case for the STAI-S, the POMS test-retest reliability is also somehow low, even 
when used with the standard (past week) instructions. However, and crucially, the test-retest 
coefficients are higher when no treatment is applied between the test and retest measures (r = 
.70 for Tension-Anxiety in psychiatric outpatients), and they decrease when external 
modifications (e.g., treatment) intervene before the retest phase (r = .51). This sensitivity to 
change is even amplified when the short-term instructions (right now) are used, providing 
good evidence for the construct validity of the Anxiety-Tension state subscale (for details on 
studies using the right now instruction set in combination with emotion-inducing paradigms, 
                                                          
8
 A less stable factor of Confusion-Bewilderment and an additional unscored Friendliness dimension were 
isolated in a subset of populations, but were not always replicated. 
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see Pillard, Atkinson, & Fisher, 1967, and McNair & Heuchert, 2005). Evidence for external 
validity has been provided by means of correlations with other measures capable of capturing 
contingent changes in state anxiety, including the STAI-S and the Positive and Negative 
Affect Schedule-Extended form (PANAS-X). The POMS Tension-Anxiety scores have been 
correlated with all the PANAS-X subscales (with past week instructions) and evidence was 
provided for convergent validity with the Fear subscale (correlation coefficient: .85) and for 
discriminant validity with all the other subscales of the PANAS-X (all r < .74).  
Several short forms of the POMS have been developed for inclusion in multi-instrument 
assessment protocols or in order to be suitable for clinical settings in which the stress or pain 
experienced by the patients require less time-consuming testing procedures. The POMS-Short 
Form (POMS-SF, Schacham, 1983) consists in 37 items derived from the original version of 
the instrument, and it allows separate factors scores as well as a TMDS; its psychometric 
properties are considered good to excellent, and in certain cases (i.e., Tension-Anxiety 
subscale) even superior to that of the original POMS version containing 65 items (see Curran, 
Andrykowsky, & Studts, 1995). The Brief POMS (Cella et al., 1987) is composed by only 11 
adjectives, and it enables to compute only a global psychological distress index. Despite the 
good psychometric properties (Cronbach‘s alpha consistently reported above .90), the 
absence of more detailed information about possible dissociations among subcomponents of 
the total score is a major disadvantage of this shortened version of the scale. A 30-items 
POMS (POMS-B) is available since 1989 (see McNair & Heuchert, 2005): this version of the 
scale is composed by five items for each of the six subscales, and it has been developed 
pruning from the original self-rating scale, taking into account the loadings of each item on 
the separate factors. As a result, its psychometric properties are roughly similar to the 65-
items POMS (consistency for the Tension-Anxiety scale is .89 in a group of psychiatric male 
outpatients and .87 in the respective female group). As for the POMS-BF, the POMS-B 
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maintains the level of specificity of the original version of the instrument due to the 
possibility of computing separate scores for the different subscales.  
2.2.2 Practical usage 
The POMS has been initially developed to measure affective states, and more specifically 
mood states. In this sense, the Tension-Anxiety factor of the scale identifies the tense mood 
as a possible counterpart of the concept of state anxiety, as directly measured for example by 
the STAI-S. Regarding the peculiarities of the POMS and its potential advantages over other 
self-rating scales, the presence of dissociated and very stable scales for Depression-Dejection 
and Anger-Hostility, besides the Tension-Anxiety scale, might turn out extremely helpful in 
further addressing the dimension-specific effects of treatments. As an example, given the 
large overlap of the anxiety and depression constructs (see Spielberger & Reheiser, 2009; 
Cella & Perry, 1986; Mineka, Watson, & Clark, 1998, or Wolitzky-Taylor, Castriotta, Lenze, 
Stanley, & Craske, 2010 for recent reviews on the comorbidity of the two disorders), a 
reduction along the depression dimension might go undetected when addressing possible 
mood changes using the STAI-S only. Consistent with this idea, evidence has been provided 
for a substantial overlap of the STAI-S score with the Total Mood Disturbance Score, which 
is a compound index and comprises all the POMS subscales (Bolmont & Abraini, 2001). This 
enhanced sensitivity of the POMS towards differences among scales is supported by the 
broad range of adjectives included. At the practical level, however, the high specificity of the 
adjective list might be problematic when the scale is administered to patients with impaired 
language or verbal skills, or to people with limited lexicon; in such cases, it might be 
preferable to use non-verbal tools, such as the Visual Analog Scale (see here below). 
However, this drawback may be overcome, since the manual of this instrument also provides 
two possible alternatives for each of the 65 adjectives, in case the respondent would ask some 
clarifications concerning the exact meaning of some of the items.  
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2.2.3 Main domains of utilization  
The POMS has been used primarily as a measure of mood. However, our systematic review 
shows that a number of studies have used the POMS more specifically, to address the role of 
physical activity or bodily treatments (e.g., Johrei healing method, aromatherapy or massage) 
specifically onto levels of state anxiety. Typically, the POMS or a combination of different 
anxiety measures (usually POMS and STAI-S, see Table 1) is administered before the 
beginning of the treatment, and repeated again after it, seeking evidence for a decrease in 
state anxiety  (see Table 1, entries 45, 54, 57, 62, 69, 70, 71, 84, 100 & 107). Likewise, 
several studies have also used the POMS to investigate, using controlled designs, the 
anxiolytic effects of different physical activities, including single bouts of dynamic 
Taekwondo exercise (entry 183), Qigong exercise (entry 89), treadmill running (entry 132) 
and cycling (entry 174). Noteworthy, our review suggests that the POMS is rather seldom 
employed in clinical settings (cf. Table 1, entries 16, 41, 62, 78, 91, 125, 140 & 182), and 
never, to our knowledge, with patients suffering from acute pain, due its somewhat lengthy 
duration of administration. The POMS is nonetheless used in pharmacological trials (entries 
44, 64, 72, 121, 159, 160 & 185). Additionally, in combination with the STAI-S and/or with 
Visual Analog Scales, the POMS is sometimes used to test for the effects of procedures of 
Acute Triptophan Depletion on mood (entries 41, 78 &125 in Table 1). 
To sum up, the results of this systematic review show that more than half of the studies 
meeting our general search criteria for this measure concern the positive influences of 
physical exercise or physical treatments, in the domains of sports and health psychology. 
Nonetheless, our review also suggests that the POMS is rather often used in 
psychopharmacology and, third, in the domain of experimental and applied psychology 
(roughly 20% of the studies reported in our review and using the POMS, see Table 1).  
2.3 Positive and Negative Affect Schedule (PANAS) 
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2.3.1 General description, main use and psychometric properties 
The Positive and Negative Affect Schedule (PANAS) was initially developed to provide a 
reliable estimate of two broad and largely independent factors implicated in emotional 
experience: Positive and Negative Affect (PA and NA). The original and most widely used 
version of the PANAS (Watson et al., 1988) is composed of 20 self-rating items 
corresponding to adjectives (e.g., Interested, Distressed) that describe different states, 
feelings and emotions. Each of the 10 terms linked respectively to NA and PA requires a 
score on a 5 points Likert scale. Each rating seeks to measure the intensity of that specific 
feeling or emotion during a given timeframe for the participant (1 = very slightly or not at all; 
5 = extremely). As was the case for the POMS, simple amendments to the original 
instructions of the PANAS can be implemented to better address state fluctuations in PA and 
NA (using instructions asking to rate the feelings ‗right now, at the present moment’), or 
instead, as a more stable measure of trait-like emotional disposition (in this case, the 
instructions are changed and state ‗you generally feel this way, that is, how you feel on the 
average’)9. Here we will primarily focus on the specific properties of the instrument when 
used to capture transient state variations (and more specifically when these changes in affect 
primarily concern the NA factor). Accordingly, the psychometric properties will be reported 
with respect to the instructions requiring ratings of present affect.  
The factorial structure of the 20 items version of the PANAS comprises only two orthogonal 
factors, each related to one of two primary dimensions of mood: Positive Affect and Negative 
Affect. The two scales exhibit acceptably high internal consistency (Cronbach‘s coefficient α 
for NA/present: .85), invariably low intercorrelations (-.15 for present instructions) and better 
test-retest reliability when the timeframe used in the instructions increases (test-retest 
correlation coefficients: NA/present: .45; NA/general: .71). The NA scale is composed by 
                                                          
9
 Between these two extremes, a wide variety of time frames can be tested, depending on the modifications 
made to the original task instructions (for details on this topic, see the technical Manual; Watson et al., 1988).  
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items with high loadings on one factor and acceptably low loadings on the other one, 
providing therefore quite pure markers of one out of two dimensions: for the 10 items in the 
NA scale, loadings on NA factor are comprised between .52 and .74, while loadings on PA 
factor are all lower than |.15| (symmetrically, similar values are reported for the items loading 
the PA dimension, see Watson et al., 1988). Additionally, the internal validity of the scale is 
high, both for convergent (NA/present: .91) and discriminant (-.15) correlations (obtained 
with factor analysis: for further details, see Watson et al., 1988). The external validity of the 
tool has been tested by means of correlation scores calculated with other instruments 
measuring distress (and psychopathology). For the purpose of this study, the only relevant 
comparison (i.e., correlations with a measure of state NA) is the one performed with the 
STAI-S (Form X, Spielberger et al, 1970), where correlations of .51 were found, indicating 
mildly good external concurrent validity.  
An expanded form of the PANAS (PANAS-X, Watson & Clark, 1994), whose psychometric 
properties closely resemble the original version (NA/present: Cronbach‘s α: .85; internal 
convergent validity.89 to .94; internal discriminant correlations: -.05 to -.16; scales 
intercorrelation: -.06) is also available
10
. Unlike the original version of the instrument, which 
is based on a conceptualization of the affective structure as a two-dimensional construct 
(composed by NA and PA, represented as distinctive and orthogonal factors), the PANAS-X 
is based on a hierarchical structure, which comprises two broad, higher order dimensions 
(again, NA and PA), each composed by several lower-order sub-scales corresponding to 
separate affective states. In this expanded scale the higher order constructs indicate the 
valence of the emotional state, while the correlated, and nonetheless distinguishable, lower 
order dimensions are specifically related to the content of the experienced affect. The eleven 
                                                          
10
 The internal validity coefficients provided for the PANAS-X were obtained with correlations between the NA 
and PA scales (PA scores non reported here) and regression-based scores on the first two Varimax Factors in the 
samples assessed with the original 60 PANAS-X Mood Descriptors.  
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sub-scales of the PANAS-X (Fear, Sadness, Guilt, Hostility, Joviality, Self-Assurance, 
Attentiveness, Shyness, Fatigue, Serenity and Surprise), composed by uneven numbers of 
items (for a total of 60 adjectives), can be further grouped into three intermediate 
subcategories on the basis of their intercorrelations and loading values on the two higher 
order dimensions (NA or PA). The Basic Negative Emotion Scales comprise items with 
highest loadings on Fear, Sadness, Guilt and Hostility, which are in turn intercorrelated and 
have high loadings on NA (convergent correlations between .69 and .79, discriminant 
correlations <|.27| for NA/present). Particularly relevant in the context of this review work is 
the Fear subscale, which has some clear resemblance with the STAI-S, and with the Anxiety-
Tension scale of the POMS. The internal consistency of the PANAS-X Fear subscale (tested 
with present instructions) is acceptably high (Cronbach‘s α: .87 in American undergraduate 
students, Watson & Clark, 1994), and its external validity, as expressed in correlations with 
the different subscales of the POMS
11
, is adequately high (convergent correlation with the 
anxiety-tension POMS dimension: .85; discriminant correlations with the other dimensions of 
the POMS: all r < .74). Although the psychometric properties of the hierarchical form of the 
PANAS (PANAS-X) have been reported to be acceptably good and stable across different 
samples (Watson & Clark, 1991 & 1992), the factorial structure of the NA sub-scales has 
been questioned (Bagozzi, 1993).  
2.3.2 Practical usage 
The PANAS Negative Affect scale does not provide a direct and explicit measure of state 
anxiety per se. Nonetheless, both the NA scale and, even more specifically, the Fear subscale 
of the PANAS-X contain items that are closely related to the definition of anxiety as a 
                                                          
11
 Note that in contrast with the other psychometric properties reported here, which were calculated with present 
instructions,  the external validity coefficients of the PANAS-X have been calculated with past few weeks 
instructions. For further details on the PANAS-X psychometric properties with different timeframe instructions, 
see Watson & Clark, (1991, 1992 & 1994).  
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‗general or long lasting state of distress, prompted by not explicit or generalized cues’ (cf. 
Lang, Davis, & Öhmans, 2000). Accordingly, these subscales have consistently been used to 
address phasic changes in anxiety (or in certain specific cases, stress). In line with this notion, 
the PANAS and PANAS-X external validity measures provided by the authors (Watson et 
al., 1988; Watson & Clark, 1994) give acceptably high convergent correlations with the 
POMS Anxiety-Tension subscale and with the State-Trait Anxiety Inventory-State Form (r = 
.85 with the POMS Anxiety-Tension subscale and .51 with the STAI-S, both with Past few 
weeks instructions, see Watson & Clark, 1994 & Watson et al., 1988, respectively). The 
critical items, which are strongly and consistently loading the Basic Negative Emotion Scales 
in the PANAS-X or the NA scale in the 20-item version of the instrument are Afraid, Scared, 
Frightened, Nervous, Jittery, Shaky, Upset and Distressed. In contrast to the STAI-S, which 
includes items assessing the Anxiety-Present and Anxiety-Absent constructs independently, 
the PANAS and PANAS-X scales do not comprise items related to the absence of anxiety. 
Nonetheless, the PANAS-X Self Assurance scale (comprising items as Fearless and 
Confident) and the Serenity subscale, belonging to the Other Affective States group and 
represented by items as Calm or Relaxed, could be used as measures of the Anxiety-Absent 
construct.  
2.3.3 Main domains of utilization 
The PANAS and the PANAS-X scales have been widely used to investigate changes in 
positive or negative affect states in healthy volunteers, mainly in experimental contexts aimed 
at either up- or down-regulating stress responses. The PANAS as outcome measure for 
anxiety has often been used in combination with anxiety-inducing procedures (see Table 1, 
entries 2, 19, 30, 40, 52, 66, 76, 115, 117, 136, 142, 146, 156, 168, 171, & 192), among 
which the TSST (see also section 2.1.3). As was the case for the application of the TSST in 
combination with the STAI-S, studies using the PANAS as a measure of anxious reactions 
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have applied experimental designs requiring multiple measurements of positive and negative 
affect, which were assessed at baseline (i.e., before the primary manipulation), a second time 
before the TSST, and a third time at the end of the speech, in such a way to be able to 
eventually model the time course of anxious reactions to multiple stressors (see entries 117, 
142 and 171 in Table 1). However, our systematic review suggests that, whereas the TSST has 
often been used in combination with the STAI-S to verify changes of the emotional responses 
in relation to the stressor, the same TSST and other anxiety induction procedures (e.g. the 
presentation of unpleasant pictures or sentences) were used in the literature in combination 
with the PANAS in order to quantify the effects of the induced stress on other cognitive 
aspects, including decision making processes or patterns of regional brain EEG activity 
(Table 1, entries 171 & 146). Furthermore, the PANAS has sometimes been used to assess 
the compensatory effects of cognitive restructuring protocols (entry 156) or positive imagery 
(entry 75) onto induced stress responses.  
Besides this main domain of application, the PANAS has also been used frequently in 
different fields (e.g., sports and health psychology), in order to assess the positive effects of 
physical exercise on mood and affect (and more specifically onto negative affect and anxious 
feelings). In this context, the PANAS has been administered before and after exercises 
varying in type (Table 1, entry 43), intensity (entries 9 & 20) or duration (entry 152). 
Interestingly, the PANAS has been also associated with the STAI-S to assess the positive 
effects of gymnastics on emotional state (entries 86 & 87), and to compare changes in levels 
of state anxiety caused by bouts of activity in various disciplines, including Yoga, walking, 
martial arts, cycling and aerobic gymnastics (entries 21, 97 & 129).  
In summary, our review shows that the PANAS and PANAS-X scales have mainly been used 
in experimental paradigms aimed at characterizing factors or conditions able to influence 
both positive and negative affect (and among the components of NA, state anxiety). By 
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contrast, it turns out that this instrument has only rarely been used with clinical populations to 
capture transient state-dependent variations in mood or affect (see entries 21, 136 and 146 in 
Table 1).  
2.4 Visual Analog Scale-Anxiety (VAS-A) 
2.4.1 General description, main use and psychometric properties 
The Visual Analog Scales, or Graphic Rating Scales, as they were originally coined, have 
been introduced in 1923 by Max Freyd, for the purpose of achieving an unbiased judgment of 
psychological or behavioral characteristics. A VAS is composed by a line whose limits are 
anchored by two terms representing the extremes of the addressed sensation, and by an 
introductory question (e.g., How anxious do you feel right now?). This form of self-rated 
measure can be used in combination with several adjectives or statements (e.g., tense, shaky, 
restless) in order to obtain a measure of these attributes, which is at the same time precise, 
accurate, sensitive to change, but also not very burdensome in completion for clinical 
populations. Additionally, due to its intrinsic simplicity, the VAS is a suitable instrument for 
repeated measurements, also in clinically restraining situations (e.g., directly in the operatory 
room). The patient is usually requested to mark the point, along the line, that corresponds best 
to the perceived intensity of the feeling that is mentioned in the question. This procedure has 
proven to be also suitable for patients with motoric or linguistic problems, or in state of acute 
stress, where omissions in more burdensome inventories (such as STAI or POMS) are 
frequent in clinical practice. The most commonly used VAS for the measurement of state 
changes in anxiety is the so-called VAS-A, composed by one single item proposing the 
question ―How anxious do you feel right now?” followed by a line delimited by two anchors 
―Not anxious at all” on one side and ―As anxious as I could be” on the other side (or similar 
statements, for example ―No Anxiety at all” and ―Worst anxiety imaginable”). With some 
exceptions (see below the VAMS description) the null anxiety anchor is usually positioned at 
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the far most left of the line, or at its bottom in case of a vertical format, while the extreme 
anxiety anchor is positioned at its right (or top). Scoring of the scale is calculated either with 
a ruler, measuring the distance in millimeters from the null anxiety anchor to the mark, or 
with stencils, which permit differentiation in the attribution of values to the positions on the 
basis of distributional properties (Freyd, 1923).  
The psychometric properties of the VAS-A have been addressed both for the horizontal and 
the vertical version of the instrument in several clinical and subclinical populations 
(Hornblow & Kidson, 1976; Vogelsang, 1988; Gift, 1989; Cline, Herman, Shaw, & Morton, 
1992; Millar, Jelicic, Bonke, & Asbury, 1995; Kindler, Harms, Amsler, Ihnde-Scholl, & 
Scheidegger, 2000; Chlan, 2004). They are quite acceptable, although internal consistency of 
the scale is not available, since it is composed by one item only. On the other hand, its 
validity has been addressed by several studies in clinical and nonclinical populations, leading 
to the conclusion that this instrument is suitable for assessing state changes in anxiety, 
knowing that the vertical version of the VAS-A seems to be more sensitive to change in 
affect than the horizontal one (Gift, 1989). The external validity has been reported in 
numerous populations by means of correlations with STAI-S scores and other measures of 
anxiety: the correlation scores range from moderately low values
12
 (.52 in Cella & Perry, 
1986; .50 in Chlan, 2004) to relatively high coefficients (.82 in Vogelsang, 1988). This wide 
variability somehow suggests that caution is needed when assuming the same psychometric 
properties for the VAS-A in different populations (see also Hornblow & Kidson, 1976, 
reporting very different correlation coefficients between STAI-S and VAS-A across several 
populations). Concurrent validity has also been calculated in respect to the POMS-Tension (r 
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 Both the VAS-A and the STAI-S presumably provide an estimate of the same, very specific, construct 
(namely, anxiety), such that these two instruments should normally share a high portion of variance. 
Accordingly, correlation coefficients ranging between .34 (Hornblow & Kidson, 1976) and .52 (Cella & Perry, 
1986) may be considered moderately low in this context.  
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= .51), while discriminant correlation coefficients were provided in the same sample with 
measures of depression (all rs < .49, Cella & Perry, 1986) 
Test-retest reliability data have been provided both in healthy populations (between .30 and 
.32 Hornblow & Kidson, 1976; >.50, Cella & Perry, 1986) and in the context of carbon 
dioxide breathing challenges in panic disorder patients (see entry 189 in Table 1). Pre-
challenge VAS-A scores, as well as post-challenge scores and difference/delta scores 
(obtained after subtracting the pre-challenge scores from the post-challenge, usually higher, 
ones) were reported for two identical sessions one week apart. Correlation coefficient 
between scores in the two sessions ranged from .058 for the pre-challenge score to .401 for 
the delta score and .709 for the post-challenge score, providing evidence for both sensitivity 
to variable situational factors (pre-challenge low correlations) and for stability in the 
sensitivity to change (high post-challenge coefficients). This study also pointed out that VAS 
delta scores might not be the best way to assess anxiety induction, because of their strong 
dependence to the (unstable) pre-challenge scores.  
Several variations in the VAS-A construction and application have been proposed in the past 
years, leading to instruments with different strengths and weaknesses: the analog scales can 
be presented in discrete Likert-scale form with verbal instructions (Verbal Anxiety Rating, 
VAR; entry 18 in Table 1), which leads to smaller omission rates as compared with the visual 
analog version of the scale, but also to a loss of responsiveness linked to the limited amount 
of discrete descriptors, as compared to the continuous version (Davey, Barratt, Butow, & 
Deeks, 2007). Alternatively, the VAS-A has been combined with other scales assessing 
emotional states, either in vertical Likert-scale format with the null anchor below (as in the 
Emotion Thermometers: Mitchell, Baker-Glenn, Granger, & Symonds, 2010 & Mitchell, 
Baker-Glenn, Park, Granger, & Symonds, 2010) or in vertical VAS format, with the neutral 
anchor above (Visual Analog Mood Scales, VAMS: Stern et al., 1997; Nyenhuis, Stern, 
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Yamamoto, Lucchetta, & Arruda, 1997). The VAMS version of the VAS-A showed good 
convergent and discriminant validity, as expressed in the correlation coefficient of the 
separate VAMS with the different POMS subscales (convergent validity coefficients of the 
Afraid VAMS with the Tension-Anxiety scale of the POMS: .34 to .54 in different samples; 
mean discriminant validity with non-homologous scales: .16 to .35; mean inter-correlation 
among VAMS: .14 to .29); acceptable psychometric properties have also been reported for 
the Anxiety Emotion Thermometer (sensitivity measured using the cutoffs of the Hospital 
Anxiety and Depression Scale: .92; specificity: 0.61).  
2.4.2 Practical usage  
All in all, systematic research has shown that the VAS-A, in its different declinations, 
generally performs well in capturing dynamic changes in experienced anxiety state, and can 
easily be used in clinical contexts. Nonetheless, some recommendations should be made in 
constructing, standardizing and even simply using VAS scales. First, a very specific unipolar 
construct should be used in the introductory question and in the verbal anchors. Since many 
feelings and states can have multiple opposites, only one dimension should be tested in each 
VAS (Freyd, 1923). The VAS-A (Hornblow and Kidson, 1976), and several other adjectives 
have been used to assess various constructs. Since the scale is not bound to specific 
questions, the experimenter or clinician has the freedom to adjust the question and the 
anchors at his own convenience. However, certain scales have been tested and standardized 
or validated in the literature, and the recommendation is to adhere as much as possible to one 
(or more) of them. Some examples of the items used in previous studies addressing the 
changes in anxiety in diverse clinical populations are the adjectives afraid and tense (used in 
the VAMS), and statements regarding the amount of perceived fear (entry 73 of table 1), or 
the possible correlates of preoperative anxiety (Kindler et al., 2000). Since the scale has been 
developed in order to match the needs of clinical populations, the instructions and the 
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introductory questions should be as simple as possible, in order to minimize omission rates, 
and contain examples of possible scores (Freyd, 1923; Davey et al., 2007). Moreover, unless 
a Likert discrete format is used, the VAS line should be continuous and not too long, since it 
should be perceived as a whole by the participant (Freyd, 1923). Nowadays, automatically 
scored electronic versions of the VAS-A are commonly available for clinical and non-clinical 
use, and evidence has been provided for their equivalence with the paper version (van 
Duinen, Rickelt, & Griez, 2008).  
Importantly, some caution is needed when assessing state anxiety levels using combinations 
of instruments including the VAS-A. This latter measure contains the word anxious; hence it 
is very overt or explicit to participants. Accordingly, it might be good practice to assess the 
VAS-A after the other measures, in order to prevent any biasing of the responses to the 
following measures due to the explicit mention of the word anxious. However, it must be 
noted that even questionnaires that are somehow more covert might prime anxious feelings, 
influencing the subsequent responses to the VAS-A. This problem is crucial in designs 
involving multiple instrument assessments, and, unfortunately, there is no ‗gold standard‘ 
rule to deal with this problem in the literature (e.g., Millar et al., 1995).  
Although the strengths of the VAS are the quick administration, the relative simplicity of the 
instructions and the smaller impact that language has on the comprehension and completion 
of the scale, some potential drawbacks of this way of assessing transient changes in state 
anxiety should be pointed out. First of all, as previously noted (Gift, 1989), some participants 
experience problems and uncertainty when translating a sensation into a spatial dimension, as 
required for the distance between a pre-defined anchor and an arbitrary mark on a straight 
line. These problems sometimes lead to clustering of the responses at the extremes and at the 
center of the scale, a phenomenon that might be partially attributed to the central tendency 
bias, a well known psychological phenomenon (Millar et al., 1995). Additionally, 
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accumulating evidence obtained by the use of the VAS-A in different populations seems to 
suggest that the distribution of the scores is not always consistent, nor are the correlations 
with other state anxiety measures (as the STAI-S or the POMS Tension-Anxiety subscale). 
These observations suggest that norms and cutoffs for high anxiety categories should be 
obtained separately for different clinical population, and that additional research on the 
matter is highly desirable.  
2.4.3 Main domains of utilization 
The VAS-A is a tool that has explicitly been developed to be administered in clinical settings. 
Hence, it is not surprising to find out in our review that a majority of the relevant studies have 
used the VAS-A with patients. Consistent with this specificity, several authors have used the 
VAS-A to explore changes in state anxiety occurring directly within the operatory theater, 
mainly in patients undergoing surgery or painful dental treatments. The choice of measuring 
anxiety with a single VAS, or a cluster of them, allows multiple repetitions of the assessment, 
even during the peri-operative period, when the patients have already received partial 
sedation (Table 1, entries 1, 73, 95 & 110). In these cases, an experimental manipulation is 
usually applied immediately preceding or instead of the pre-operatory medication, and the 
VAS-A is therefore used to test for the efficacy of the target manipulation to eventually 
reduce levels of state anxiety (e.g., entries 1, 32, 61, 95, 103, 110, 187 & 195). At the same 
time, our systematic literature review suggests that a second main domain of utilization of the 
VAS-A, concerns the psychopathology and neuropharmacology of disorders belonging to the 
anxiety spectrum, as Generalized Anxiety Disorder (GAD), Post-Traumatic Stress Disorder 
(PTSD), Phobias and Panic Disorder (See entries 4, 10, 12, 24, 41, 63, 78 112 and 189 in 
Table 1). Moreover, several studies have explored the modulation of anxiety levels in other 
patient populations as a function of anxiety induction procedures (see entries 22, 85, 99 and 
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153 in table 1) or dedicated pharmacological manipulations (e.g., entries 41, 78, 125, and 
entry 79 for a validation study on healthy participants.  
3. Comparative evaluation of the four instruments 
3.1. Overlap vs. differences for the six classification variables 
When carefully looking at Table 1 and the way the six variables (section 1.2.3) account for 
the heterogeneity found across the 197 retained studies, we can identify some overlap, as well 
as interesting differences among the four instruments in the way they have been used in the 
literature to capture transient state-dependent fluctuations in anxiety. Most striking is their 
selective repeated association with different contexts or situations, as clearly reflected when 
considering the variables ―Domain‖ and ―Population‖ concurrently (see Fig. 1d). In this 
section, for each grouping variable separately, we first discuss the most evident similarities 
and differences between the four instruments, before we turn to some general conclusions and 
recommendations. 
Construct: “Anxiety”, “Affect”, “Mood”, “Stress”, “Distress” or “Fear”. This variable 
corresponds to the theoretical or empirical concept embraced by the authors in their original 
contribution: it always relates to the state anxiety domain, but sometimes inclusion of more 
specific or more general constructs was necessary. Based on our systematic review (see Table 
1), it becomes obvious that the STAI-S and the VAS-A were the most widely used 
instruments when the underlying construct was clearly and transparently defined as 
―anxiety‖. Presumably, this relates to the unambiguous definition underlying the construct in 
case of the STAI, and the high specificity allowed by a single-item instrument for the VAS-
A. Interestingly, our review shows that the most common multiple assignment is the 
combination of “anxiety” and “mood”, whose measurements have been usually achieved by 
using the POMS in combination with the STAI-S. Interestingly, in several studies the concept 
of state anxiety closely resembles the concept of ―negative mood‖ or ―negative state‖, and in 
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these specific case either  the POMS alone (cf. Table 1, entries 14, 131, 135, 158 & 174) or 
the PANAS alone (entries 30, 40, 97 & 156) was used. Conversely, the STAI, initially 
designed to selectively measure state anxiety, has been used sometimes to measure other 
constructs such as ―negative affect‖ (see entry 25 in Table 1) ―positive affect‖ (entry 114) 
―stress‖ (entries 123 and 175) or ―mood‖ (see entries 87 & 185). 
Domain: “Treatment”, “Experimental”, or “Applied”. At first sight, our review suggests an 
uneven distribution of the studies along these three categories for the four instruments. 
Whereas three of the four instruments (namely the STAI, the PANAS and the VAS) have 
primarily been used in studies focusing on experimental designs aimed at modeling changes 
of the phasic anxious responses, the POMS is distinctive as it has mainly been used in studies 
designed to treat anxiety states. This difference becomes even more obvious when plotting 
the four instruments onto a bi-dimensional axis taking into account two independent 
descriptive variables concurrently, namely ―Domain‖ and ―Population‖ (Fig. 1d). Figure 1d 
suggests non-overlapping mean positions for the different instruments along these two axes 
with a marked shift for the POMS towards the treatment direction, relative to the three other 
instruments.  
Population: “Clinical” vs. “Non Clinical”. For this variable as well, differences are visible 
across the four pre-selected instruments. As can be seen from Figures 1b & 1d, the PANAS 
has mostly been used in non-clinical samples while the VAS has been used equally in clinical 
and non-clinical samples to measure state-dependent variations in anxiety. The STAI-S and 
the POMS occupy relatively intermediate positions as compared to these two ―extreme‖ cases 
(see Fig. 1b). 
Manipulation: “Central”, “Peripheral” or “No Manipulation”. With respect to this 
grouping variable, again, dissociations are evidenced for the four instruments. As it turns out 
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based on our review work, the POMS is distinctive as many studies that have used this 
instrument focused on manipulations targeting the body (―Peripheral‖). By comparison, a 
majority of studies using the VAS (and to a lesser degree either the STAI-S or the PANAS) 
actually involved manipulations acting on the cognitive or central nervous system (―Central‖, 
see Figure 2a).  
Direction of the effect: ―Induction” vs. “Regulation”. Figure 2b shows the relative 
distribution of studies for this variable, separately for each self-report instrument. As can be 
readily seen, a strong difference is observed between the POMS and the VAS: while most of 
the studies using the POMS were primarily designed to assess down-regulatory affective 
processes, a majority of studies using VAS were set up to measure the reactivity of the 
organism in response to stress or anxiety induction. Interestingly, our review also shows that 
the highest proportion of studies including a combination of up- and down-regulatory 
processes actually had the STAI-S as outcome measure (Table 1).  
Approach: “Descriptive” vs. “Causal”. Our review suggests that this variable was the one 
providing the lowest discrimination power among the four instruments (see Fig. 1c). 
Although the number of studies included in our review varies substantially from one 
instrument to the other (ranging from N = 130 for the STAI-S to N = 33 for the PANAS), 
most of the studies were classified as ―Causal‖ (i.e., the study was designed with the aim to 
influence levels of state anxiety), relative to ―Descriptive‖ (i.e., the study was not set up for 
this goal), regardless of the instrument used (see Fig. 1c). 
Based on this systematic evaluation of the four instruments using our six variables, a main 
conclusion that can be drawn is the observation of asymmetries or imbalances in the domains 
of utilization of these four instruments (STAI, POMS, PANAS and VAS). Based on our 
systematic review, it becomes apparent that these four instruments are used in different 
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research domains, even if they are all applied to obtain a measure of state-dependent 
fluctuations in anxiety. When the testing takes place in a clinical environment, VASes clearly 
dominate, and are the most commonly used instruments, while by comparison, the use of the 
PANAS, for example, remains extremely limited (see Figures 1b & 1d). On the other hand, 
our review also indicates that when fluctuations in anxiety are measured and experimental 
designs are explicitly used, the STAI-S is the dominant instrument, and seems to be the ‗gold 
standard‘ measure. In these cases, it must be emphasized that the construct under study is 
usually strictly and clearly characterized as ―anxiety‖, as opposed to ―affect‖, ―mood‖, or 
―stress‖. Likewise, our review shows that when the research question involves measuring 
changes in anxiety (or mood) in response to specific treatment conditions administered to 
non-clinical samples, a majority of studies have used the POMS, which often appears to be 
considered the most valid instrument in these cases, because of its enhanced specificity in 
capturing and disentangling discrete effects of the manipulation on putative orthogonal 
factors (e.g., anxiety, depression or anger).  
As anticipated in the introduction section, our review work did not aim, however, at 
establishing whether these differences found for the domains of utilizations of these four 
instruments actually result from their non-overlapping intrinsic characteristics (including at 
the psychometric level, as reviewed here above), rather than a simple tradition to use a 
specific instrument within a specific domain of investigation. To the best of our knowledge, 
this is still an empirical question, and no previous work has directly compared the sensitivity 
of all these four instruments in capturing fine-grained fluctuations in anxiety, when they 
occur within a short time period. Importantly, it must be noted that systematic comparisons 
between these instruments have been made (e.g., Davey et al., 2007; Chlan, 2004; Cella & 
Perry, 1986), but these comparative efforts were mainly carried out to better characterize 
these instruments when considered only in a very specific domain at a time, as opposed to a 
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systematic comparison of the sensitivity of these instruments across several or multiple 
domains. However, as a first attempt towards more systematic comparisons of these four 
instruments, we have extracted from the studies  included in our review (when available), the 
reported psychometric properties, and summarized them in a Table (Table 2, supplementary 
material). From Table 2 it becomes obvious that certain properties of the measures match 
rather well with the ones provided in the manuals (see for example the internal consistency 
scores). However, it is also clear that other properties (such as test-retest reliability and inter-
measure correlations) are not always reported. Moreover, when that is the case, inter-
instrument comparisons are often only partial, and moreover generalization across domains 
remains very difficult, due to the limited use of certain measures in certain domains. 
Nonetheless, with respect to basic psychometric properties, these four instruments are highly 
comparable and they provide reliable tools to measure state-dependent changes in anxiety. 
However, it is clear that more psychometric and comparative work is needed to precisely 
determine the respective sensitivity (and specificities) of each of these four instruments in 
relation to a specific domain of application.  
3.2. General recommendations for the use of the STAI, POMS, PANAS and VAS 
Our systematic review is also informative, as it enables to raise a few recommendations for 
the use of these four instruments in the context of rapid state-dependent fluctuations in 
anxiety. First of all, it seems particularly important to provide a clear, good and appropriate 
operationalization of the construct or variable under study, prior to the actual selection of a 
given instrument. Does the state-dependent changes under study concern anxiety per se, or 
instead negative mood, affect, stress or any other underlying construct? It seems relevant to 
clarify this issue from the outset, before using a specific instrument. If the core of the 
research question concerns ―state anxiety‖, and the definition of anxiety most likely adheres 
to the one put forward by Spielberger (1983), the use of the STAI-S may be preferred, 
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because of its wide item-intensity sensitivity, which makes it especially suitable tool to test 
state-dependent fluctuations in a variety of situations and samples (as shown in this review, 
see Table 1). If the study is performed with clinical patients and the protocol includes more 
restrictions or constrains (e.g. limited time to fill out a given questionnaire), the VAS-A 
stands as a the most optimal instrument to measure state-dependent variations in anxiety, 
keeping in mind the good correlation of the VAS-A with the STAI-S. Nonetheless, as directly 
pointed out by authors who compared the performance of the two instruments in clinical 
settings, some caution is needed when comparing results obtained using these two 
instruments, due to their different discriminant validity and sensitivity (Davey et al., 2007, 
and entries 18 & 103 in table 1; see also Table 2). Furthermore, our review also suggests that 
the PANAS or PANAS-X has explicitly been used in the literature not only as a measure of 
affect, but also of anxiety or negative mood (e.g., entries 25, 87, 97, 142 and 169 in Table 1). 
In particular, when the construct entailed is ―fear‖ (rather than pure anxiety), the PANAS-X 
or a single VAS (e.g., entry 24 or 73) have been the preferred measures. Obviously, when 
more complex changes in affective state (as opposed to changes in the specific anxiety 
subcomponent), are targeted by the manipulation, the PANAS remains the most relevant 
instrument, although occasionally Positive Affect has been measured by using the STAI as 
well (e.g., entry 114 in table 1). Finally, the POMS remains the most suitable instrument in 
case not only the tension component of anxiety is under interest, but also the mood condition 
in a broader sense, and when specific effects onto diverse components of mood are 
hypothesized, also in light of the strong comorbidity between anxiety and depression. 
However, our systematic review also shows that, besides the POMS, other measures 
capturing changes in levels of state anxiety have been used when the construct under 
investigation was mood (e.g., entry 52, 86, 87, 97, 169 or 185), and might therefore be 
considered for future use.  
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Obviously, our review work represents only a first, probably imperfect, attempt, aimed at 
classifying mostly at a descriptive level a large set of studies published across many different 
domains in the affective science literature, but which all share measurements of state anxiety 
using standard self-report measures. Based on the results of this first effort, it becomes clear 
that more research (including psychometric work) aimed at directly comparing these 
instruments (not so much with the aim to find similarities, but instead to better delineate the 
subtle differences and reciprocal strengths among them) would be desirable at this point. As 
such, our review may be a valuable first step for further research which will eventually help 
researchers selecting the most appropriate instrument (or combination of instruments) in light 
of their specific research question and domain.  
3.3 Added value of multiple measures? 
We have to acknowledge, based on our review work, that various combinations of these 
measures have been made in the literature, although it does not always appear clear why a 
combination, instead of a single instrument, was actually preferred. Among the studies using 
multiple assessment instruments for measuring state changes in anxiety, it must be noted that 
a few inconsistencies were noted, and as such, they may be informative. Hence, in a small 
number of studies (i.e., 11/83 where more than one instrument was used in the study), 
different results were obtained for the different instruments, suggesting some discrepancy. 
Although these inconsistencies remain overall limited (i.e., 13% of the studies in which 
multiple assessment tools were used), it is interesting to note that this ratio is comparable for 
the different combinations used: it ranges from 11% (when combining STAI-S and VAS-A) 
to 13% (when associating STAI-S and POMS). Notably, the authors often used multiple 
measures presumably in order to increase the number of variables tested at a specific time: 
for example, de-Paris et al. (2003) used a cluster of VASes to test anxiety, while the POMS-
BI was also used concurrently, but to assess state-dependent changes in mood. Nonetheless, 
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in this study, results for the POMS Tension-Anxiety scale showed no effect of the 
manipulations (i.e. the implementation of the TSST while two different doses of Gabapentine 
were administered, relative to a placebo condition), although results for the VAS-Tension 
showed significant increases in response to the stressor. This type of dissociation between 
different instruments that are nonetheless assumed to tap into the same construct was also 
acknowledged by other authors, in the context of very diverse experimental designs, and with 
the use of different combinations of instruments (entries 21, 25, 72, 108, 110, 113, 140, 144, 
149, 190). Obviously, in these cases where inconsistencies for the different instruments are 
reported, the question could be raised as whether a genuine effect of the manipulation in 
changing state anxiety levels could be assumed. Related to this fundamental question, is also 
the interrogation about how to deal with such inconsistencies when they appear, and whether 
the use of multiple measures (for example, using both STAI-S and VAS-A to assess changes 
in levels of anxiety provoked by a given manipulation) is truly desirable. It is difficult to 
make any recommendation about the use of a single, as opposed to multiple measures, as this 
question would need to be answered formally both at the empirical and theoretical levels, and 
to the best of our knowledge, no study has tackled this specific issue so far. As a caveat, we 
can add that if the two (or more) measure inform about the same construct (―state anxiety‖), 
then using them in combination would not bring any additional information, as these 
measures would be merely redundant. Alternatively, if capitalizing on the differences 
between the instruments is the elective strategy to be eventually able to better describe the 
composite effects of a manipulation, then inconsistencies for these measures are actually 
informative and desirable, because in this latter case, they enable to rule out generic effects, 
and allow revealing more specific modulations. Thus, when using multiple measures and 
obtaining inconsistencies in the results for changes in state anxiety, this may be perceived as 
either as a positive outcome or not, depending on the way the added value for using multiple 
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measures is articulated by the authors, as well as the way these inconsistencies are thoroughly 
discussed in the study. Therefore, we can only formulate here a prudent recommendation, 
which is to use a single measure to capture ―rapid‖ state-dependent changes in anxiety, unless 
specific conditions are met, and the added value of multiple measures has been clarified.  
3.4 Conclusions 
The main goal of our review was to provide a clear and accessible reading structure for the 
numerous scientific reports that have explored across diverse domains ―rapid‖ state-
dependent variations in anxiety using a limited set of self-report measures (STAI, POMS, 
PANAS or VAS). A total of 197 studies that fulfilled these specific criteria were eventually 
included in our review. The rationale was then to perform a systematic ―data-driven‖ 
classification of this large pool of studies, using descriptive grouping variables providing the 
potential to better structure and delineate boundaries in this large set of heterogeneous 
studies. This work enables to show that these four different dominant instruments actually 
map onto different research domains, where the intrinsic specificities of each tool in 
capturing these state-dependent variations in anxiety seem to have been exploited and 
maximized. As such, our review work may be valuable for future research, as it provides a 
coherent and reproducible framework to assess the specificities and overlap between the four 
instruments (STAI, POMS, PANAS and VAS), which have been most commonly used in the 
literature to assess rapid changes in state anxiety in various situations and contexts.  
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Effect 
Approach 
1 Abdul-Latif et al., 2001 x   x  Anx Tr Clinical Central Regulation Causal 
2 Abercrombie, Kalin, & Davidson, 2005   x  x Aff Exp Non clinical Central Induction Descriptive 
3 Abrams et al., 1987 x   x  Anx Exp Non clinical Central Induction Causal 
4 Abrams et al., 2002 x   x  Anx Exp Clinical Central Induction Causal 
5 Amir et al., 2008 x     Anx Tr Non clinical Central Ind/Reg Causal 
6 Andrykowski, & Redd, 1987    x  Anx Applied Clinical No manipulation Descriptive 
7 Andrykowski, Redd, & Hatfield, 1985    x  Anx Applied Clinical No manipulation Descriptive 
8 Aragon, Farris, & Byers,2002    x  Anx Tr Clinical Central Regulation Causal 
9 Arent et al., 2005 x  x   Aff Exp Non clinical Peripheral Regulation Causal 
10 Argyropoulos et al., 2004 x   x  Anx Exp Clinical Central Induction Causal 
11 Arizono et al., 2000 x   x  Anx Tr Clinical Central Regulation Causal 
12 Arntz, Merckelbach, & de Jong, 1993    x  Anx Exp Clinical Central Ind/Reg Causal 
13 Auquier et al., 1995 x     Anx Applied Clinical No manipulation Descriptive 
14 Baker, & Guttfreund, 1993 x     Anx/Mood Exp Non clinical Central Induction Causal 
15 Baron, Logan, & Hoppe, 1993 x   x  Anx Tr Non clinical Central Regulation Causal 
16 Bartholomew, Morrison, & Ciccolo,2005  x    Mood/Aff Tr Clinical Peripheral Regulation Causal 
17 Benedetti et al., 2003 x     Anx Exp Clinical Central Regulation Descriptive 
18 Benotsch et al., 2000 x   x  Anx Exp Clinical No manipulation descriptive 
19 Bernat et al., 2001 x  x   Anx Exp Non clinical Central Induction Descriptive 
20 Bixby, Spalding, & Hatfield, 2001   x x  Mood/Aff Exp Non clinical Peripheral Regulation Causal 
21 Bodin, & Martinsen, 2004 x  x   Anx Tr Clinical Peripheral Regulation Causal 
22 Bogaerts et al., 2010    x  Anx Exp Clinical Peripheral Induction Causal 
23 Bond, Shine, & Bruce, 1995 x   x  Anx Exp Non clinical Central Induction Causal 
24 Bowen et al., 2006    x  Anx Applied Clinical No manipulation Descriptive 
25 Bradley et al., 2009 x  x   Anx Tr Non clinical Peripheral Regulation Causal 
26 Bringman et al., 2009 x     Anx Tr Clinical Central Regulation Causal 
27 Bringuier et al., 2009 x   x  Anx Applied Clinical No manipulation Descriptive 
28 Britt et al., 2001 x    EAS Anx Exp Non clinical Central Ind/Reg Causal 
29 Bruera et al., 2008 x     Anx Tr Clinical Central Regulation Causal 
30 Bruning, & McMahon, 2009 x  x   Anx/Mood Exp Non clinical Central Induction Causal 
31 Buckelew et al., 1992 x   x  Anx Applied Clinical No manipulation Descriptive 
32 Campeau et al., 2007    x  Anx Tr Clinical Peripheral Regulation Causal 
33 Carrillo et al., 2001 x x    Anx Exp Non clinical Central Induction Causal 
34 Carter et al., 1995 x     Anx Exp Clinical Central Ind/Reg Causal 
35 Caumo et al., 2000 x     Anx Exp Clinical No manipulation Descriptive 
36 Chan et al., 2003 x     Anx Tr Clinical Central Regulation Causal 
37 Chua et al., 1999 x   x  Anx Exp Non clinical Central Ind/Reg Causal 
38 Cinciripini et al., 2006     x Aff/Mood Exp Non clinical Central Induction descriptive 
39 Clark, & Golshan, 2008 x     Anx Tr Clinical Peripheral Regulation Causal 
40 Cools et al., 2005   x x  Anx/Mood Exp Non clinical Central Induction Descriptive 
41 Corchs et al., 2009 x x  x HAM-A Anx Exp Clinical Central Induction Causal 
42 Cruise et al., 1997 x     Anx Tr Clinical Central Regulation Causal 
43 Daley, & Maynard, 2003   x   Aff Exp Non clinical Peripheral Regulation Descriptive 
44 de-Paris et al., 2003  x  x  Anx Exp Non clinical Central Ind/Reg Causal 
45 Diego et al., 1998 x x  x  Anx Tr Non clinical Peripheral Regulation Causal 
46 Donoyama, Munakata, & Shibasaki, 2010 x     Anx Tr Non clinical Peripheral Regulation Causal 
47 Duka et al., 1988 x     Anx Exp Non clinical Central Regulation Descriptive 
48 Durkin, & Paxton, 2002    x  Anx Exp Non clinical Central Induction Causal 
49 Edwards, Burt, & Lipp, 2010     ARQ Anx Exp Non clinical Central Induction Causal 
50 Ekwall, Gerdtz,& Manias, 2009    x  Anx Applied Non Clinical No manipulation Descriptive 
51 Erb et al., 1998 x     Anx Tr Clinical Central Regulation Causal 
52 Eubank, Collins, & Smith, 2002   x   Anx Exp Non clinical Central Induction descriptive 
53 Ferrer-Garcia, & Gutiérrez Maldonado, 2005 x     Anx Exp Clinical Central Induction Causal 
54 Field et al., 1996 x x    Anx Tr Non clinical Peripheral Regulation Causal 
55 Focht, & Koltyn, 1999 x x    Anx Tr Non clinical Peripheral Regulation Causal 
56 Fox et al., 2001 x     Anx Exp Non clinical Central Induction Causal 
57 Fumoto et al., 2004 x x    Anx Tr Non clinical Peripheral Regulation Causal 
58 Garvin, & Damson, 2008 x x    Anx Exp Non clinical Central Induction Descriptive 
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59 Gaudreau, Blondin, & Lapierre, 2002   x   Aff Applied Non clinical Peripheral No Manipulation Descriptive 
60 Geeraerts et al., 2005 x   x  Anx Exp Non clinical Central Induction Causal 
61 Gejervall et al., 2005 x   x  Anx Tr Clinical Peripheral Regulation Descriptive 
62 Gilbert, Parker, & Claiborn, 1978  x    Anx Tr Clinical Central Regulation Causal 
63 Goldin et al., 2009    x  Aff Exp Clinical Central Induction Causal 
64 Grasing et al., 1996 x x  x  Anx/Mood/Aff Exp Non clinical Central Induction Descriptive 
65 Grassi, Gaggioli, & Riva, 2009 x  x  x  Anx Tr Non clinical Central Regulation Causal 
66 Grillon et al., 2003 x  x x  Anx Tr Non clinical Central Ind/Reg Causal 
67 Gutierrez-Maldonado et al., 2006 x     Anx Exp Clinical Central Induction Causal 
68 Hale, & Raglin, 2002 x     Anx Tr Non clinical Peripheral Regulation Causal 
69 Hatayama et al., 2008 x x    Anx/Mood Tr Non clinical Peripheral Regulation Causal 
70 Hayasaka et al., 2008 x x    Anx/Mood Tr Non clinical Peripheral Regulation Causal 
71 Hayasaka et al., 2009 x x     Anx/Mood Tr Non clinical Peripheral Regulation Causal 
72 Head et al., 1996 x x    Anx/Mood Exp Non clinical Central Ind/Reg Causal 
73 Heikkila et al., 1998 x   x HADS-A Fear Applied Clinical No manipulation Descriptive 
74 Hofer et al., 2003 x     Anx Exp Clinical Central Regulation Descriptive 
75 Holmes, Lang, & Shah, 2009 x  x   Anx Tr Non clinical Central Ind/Reg Causal 
76 Holmes, & Mathews, 2005 x     Anx Exp Non clinical Central Induction Causal 
77 Holmes et al., 2008 x     Anx/Aff Exp Non clinical Central Ind/Reg Causal 
78 Hood et al., 2010 x x  x  Anx Exp Clinical Central Induction Causal 
79 Hood et al., 2006 x   x  Anx Exp Non clinical Central Induction Causal 
80 Hopko,  Hunt, & Armento, 2005    x  Anx Exp Non clinical Central Induction Causal 
81 Hughes, & Kendall, 2008     SUDS Anx Exp Clinical Central Regulation Descriptive 
82 Ihme, & Mitte, 2009 x     Fear Exp Non clinical Central Induction Descriptive 
83 Iizawa et al., 2004 x     Anx Tr Clinical Central Regulation Causal 
84 Imura, Misao, & Ushijima, 2006 x x    Anx/Mood Tr Non clinical Peripheral Regulation Causal 
85 Jacobsen et al., 1995    x  Anxiety/Distress Exp Clinical Central Induction Causal 
86 Järvekülg, 2005 x  x    Anx/Aff Exp Non clinical Peripheral Regulation Descriptive 
87 Järvekülg, Neissaar, & Viru, 2001 x  x   Anx Exp Non clinical Peripheral Regulation Descriptive 
88 Jerabek et al., 1998 x     Anx Exp Non clinical Central Induction Causal 
89 Johansson, Hassmén, & Jouper, 2008 x x       Anx/Mood Tr Non clinical Peripheral Regulation Causal 
90 Juliano, Brandon, & Moffitt, 2002 x     Anx Exp Non clinical Central Ind/Reg Descriptive 
91 Kagaya et al., 2001  x    Anx Tr Clinical Central Regulation Descriptive 
92 Kassel, & Unrod, 2000 x     Anx Exp Non clinical Central Ind/Reg Causal 
93 Kennedy, & Newton, 1997  x    Mood Tr Non clinical Peripheral Regulation Causal 
94 Kerr et al., 2005     TESI Anx Applied Non clinical No Manipulation  Descriptive 
95 Kimberger, Illievich, & Lenhardt, 2007 x   x  Anx Tr Clinical Peripheral/Central Regulation Causal 
96 Koukounas, & McCabe, 2001    x  Anx Exp Non clinical Central Induction Descriptive 
97 Kraemer, & Marquez, 2009 x  x    Anx/Mood Tr Non clinical Peripheral Regulation Causal 
98 Kreutz et al., 2004   x   Aff Tr Non clinical Central Regulation Causal 
99 Krueger et al., 2005 x   x  Anx Exp Clinical Central Induction Descriptive 
100 Laidlaw et al., 2006 x x     Anx Tr Non clinical Central Ind/Reg Causal 
101 Law, Logan, & Baron, 1994 x   x  Anx Tr Non clinical Central Regulation Causal 
102 LeBlanc et al., 2008 x     Anx/Stress Exp Non clinical Central Induction Descriptive 
103 Lepage et al., 2001 x   x  Anx Tr Clinical Central Regulation Causal 
104 Li et al., 2000 x x    Anx/Mood Exp Non clinical Central Induction Causal 
105 Liotti et al., 2000    x  Anx Exp Non clinical Central Induction Causal 
106 Litvin, & Brandon, 2010 x    x Anx Exp Non clinical Central Induction Descriptive 
107 Liu et al., 2005  x    Mood Tr Non clinical Peripheral Regulation Causal 
108 Lu et al., 2004 x   x BAI Anx Tr Non clinical Central Ind/Reg Causal 
109 Lucas et al., 2006 x     Anx/Stress Exp Non clinical Central Induction Causal 
110 Man et al., 2003 x   x  Anx Tr Clinical Central Regulation Causal 
111 Martelli et al., 1987 x     Anx Tr Clinical Central Regulation Causal 
112 Masdrakis et al., 2009 x   x  Anx Exp Clinical Central Induction Causal 
113 Masters et al., 2003 x x    Anx/Aff Exp Non clinical Peripheral Regulation Causal 
114 Mathews,& Mackintosh, 2000 x     Anx Exp Non clinical Central Induction Causal 
115 McDermut, & Haaga, 1998   x   Aff Exp Non clinical Central Induction Causal 
116 Meinberg, & Yager, 1985 x     Anx Exp Non clinical Central Regulation Descriptive? 
117 Mendonca-de-Souza et al., 2007   x   Anx/Stress Exp Non clinical Central Induction Causal 
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118 Mercer, Warson, & Zhao, 2010 x  x   Anx Tr Non clinical Central Regulation Causal 
119 Merckaert et al., 2009 x     Anx Exp Clinical Central Induction Descriptive 
120 Miller, Bartholomew, & Springer, 2005   x   Aff Tr Non clinical Peripheral Regulation Causal 
121 Miller, Taylor, & Tinklenberg, 1988  x  x  Mood Exp Non clinical Central Regulation Descriptive 
122 Mitchell, MacDonald, & Knussen,2008 x     Anx Tr Non clinical Central Ind/Reg Causal 
123 Modena et al., 1989 x     Anx Exp Clinical Central Induction Causal 
124 Moser, Hajcak, & Simons, 2005     SUDS Anx Exp Clinical Central Induction Descriptive 
125 Munafo, Hayward, & Harmer, 2006  x  x  Anx Exp Clinical Central Induction Causal 
126 Muzzarelli,Force, & Sebold, 2006 x     Anx Tr Clinical Peripheral Regulation Causal 
127 Nainis et al., 2006 x     Anx Tr Clinical Central Regulation Causal 
128 Nakane et al., 2002 x     Anx/Stress Tr Non clinical Central Ind/Reg Causal 
129 Neissaar et al., 2002 x  x   Anx Tr Non clinical Peripheral Regulation Descriptive 
130 Noto et al., 2005 x     Anx/Stress Exp Non clinical Central Induction Descriptive 
131 O'Brien, Terry, & Jimmieson,2008  x    Anx/Mood/Aff Exp Non clinical Central Induction Causal 
132 O'Halloran, Murphy, & Webster, 2004  x    Mood Tr Non clinical Peripheral Regulation Causal 
133 Okawa, Ichinohe, & Kaneko, 2005    x  Anx Exp Non clinical Central Induction Causal 
134 Oldman, Moore, & Collins, 2004 x   x  Anx Exp Clinical Central Regulation Descriptive 
135 Oliveira, Gouveia, & Oliveira, 2009  x    MRT Anx/Mood Applied Non clinical No Manipulation  Descriptive 
136 Park et al., 2009 x  x   Anx Exp Clinical Central Induction Causal 
137 Parr, & Cartwright-Hatton, 2009 x     Anx Tr Subclinical Central Ind/Reg Causal 
138 Perry et al., 1994    x  Anx Exp Clinical No manipulation  Descriptive 
139 Perry et al., 1990    x  Anx Applied Clinical No manipulation Descriptive 
140 Petruzzello et al., 2009 x x  x  Anx/Mood Tr Clinical Peripheral Regulation Causal 
141 Philippot, Baeyens, & Douilliez, 2006 x     Anx Tr Non clinical Central Regulation Causal 
142 Phillips, & Giancola, 2008   x   Anx Exp Non clinical Central Induction Causal 
143 Polman et al., 2007  x  x  Mood Applied Non clinical No Manipulation  Descriptive 
144 Poma et al., 2005 x   x  Anx Exp Non clinical Central Induction Causal 
145 Prabhu et al., 2009 x   x  Anx Tr Clinical Central Regulation Descriptive 
146 Rabe et al., 2006   x   Anx Exp Clinical Central Induction Causal 
147 Raes et al., 2003 x   x  Anx Exp Non clinical Central Induction Descriptive 
148 Raglin, & Wilson, 1996 x     Anx Tr Non clinical Peripheral Regulation Causal 
149 Rausch, Gramling, & Auerbach, 2006 x    SSSSS-S Anx Tr Non clinical Central Regulation Causal 
150 Redd et al., 1987    x  Anx Tr Clinical Central Regulation Causal 
151 Reinecke, Rinck, & Becker, 2006 x     Anx Exp Clinical Central Induction Descriptive 
152 Rejeski et al., 1995   x   Aff Tr Non clinical Peripheral Regulation Causal 
153 Ren et al., 2009    x  Anx Exp Clinical Central Induction Causal 
154 Rinck et al., 2005 x     Anx Exp Subclinical Central Induction Descriptive 
155 Robb, 2000 x   x  Anx Tr Non clinical Central Regulation Causal 
156 Rodebaugh et al., 2009 x  x   Anx/Mood Tr Subclinical Central Ind/Reg Causal 
157 Rogers, & Revelle, 1998     MSQ-R Mood Exp Non clinical Central Ind/Reg Descriptive 
158 Rosa et al., 2004  x    Anx/Mood Exp Non clinical Peripheral Regulation Descriptive 
159 Ruijter et al., 2000 x x    Anx/Mood Exp Non clinical Central Induction Descriptive 
160 Ruijter, Lorist, & Snel, 1999 x x    Anx/Mood Exp Non clinical Central Induction Descriptive 
161 Sablowski, & Herrmann, 1986 x     Anx Applied Clinical No manipulation Descriptive 
162 Schmid-Leuz et al., 2007     SUDS Anx Tr Non clinical Central Ind/Reg Causal 
163 Schneider et al., 2003 x     Anx Tr Clinical Central Regulation Causal 
164 Schunck et al., 2008 x   x HAM-A Anx Exp Non clinical Central Induction Causal 
165 Schwerdtfeger, Schmukle, & Egloff, 2006    x  Aff Exp Non clinical Central Induction Causal 
166 Scott, McNaughton, & Polman, 2006  x    Anx Exp Non clinical Sleep deprivation Descriptive 
167 Shioiri et al., 2006 x     Anx Exp Clinical Central Induction Descriptive 
168 Sideridis, 2008   x   Anx Exp Non clinical Central Induction Descriptive 
169 Simpson et al., 2008   x   Mood/Aff Applied Non clinical No manipulation Descriptive 
170 Slaven, & Lee, 1997  x    Mood Exp Non clinical Peripheral Regulation Descriptive 
171 Starcke et al., 2008 x  x   Anx/Stress/Aff Exp Non clinical Central Induction Descriptive 
172 Startup, & Davey, 2001    x  Anx/Mood Exp Non clinical Central Ind/Reg Causal 
173 Steinberg et al., 1998     x Mood Tr Non clinical Peripheral Regulation Descriptive 
174 Steptoe, & Cox, 1988  x     Anx/Mood Tr Non clinical Peripheral Regulation Causal 
175 Strentz, & Auerbach, 1988 x     Anx/Stress Exp Non clinical Central Induction Causal 
176 Strigo et al., 2002 x     Anx Exp Non clinical Central Induction Descriptive 
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.N Reference 
STAI 
State 
POMS PANAS VAS Other Construct Domain Population Manipulation 
Direction of the 
Effect 
Approach 
177 Sukegawa et al., 2008 x     Anx Applied Clinical No manipulation Descriptive 
178 Swartzman, Edelberg, & Kemmann, 1990 x     x   Anx/Stress Exp Non clinical Central Induction Causal 
179 Swendsen, 1998    x MAACL Anx Applied Non clinical No manipulation Descriptive 
180 Tang, & Gibson, 2005    x  Anx Exp Non clinical Central Induction Causal 
181 Thompson, Altmann, & Davidson, 2004 x     Anx Exp Non clinical Central Induction Causal 
182 Tornek et al., 2003 x x    Anx/Mood Tr Clinical Central Regulation Causal 
183 Toskovic, 2001  x    Mood Tr Non clinical Peripheral Regulation Causal 
184 Tovilovic et al., 2009 x     Anx Exp Non clinical Central Induction Causal 
185 Tulen et al., 1993 x x    Anx/Mood Exp Non clinical Central Induction Descriptive 
186 Urech et al., 2010 x     Anx Tr Non clinical Peripheral Regulation Causal 
187 Vadalouca et al., 2009 x   x  Anx Tr Clinical Central Regulation Causal 
188 van der Bij et al., 2003 x     Anx Exp Non clinical Central Regulation Descriptive 
189 Verburg et al., 1998    x  Anx Exp Clinical Central Induction Causal 
190 Villani, Riva,& Riva, 2007 x  x x  Anx Tr Non clinical Central Regulation Causal 
191 Vujanovic, & Zvolensky, 2009     SUDS Anx Exp Non clinical Central Induction Descriptive 
192 Weisberg et al., 2001   x   Anx Exp Non clinical Central Induction Descriptive 
193 Werner et al., 2009 x     Anx Exp Non clinical Central Induction Causal 
194 Wilson, MacLeod, & Mathews, 2006    x  Anx Exp Non clinical Central Ind/Reg Causal 
195 Wolanskyj et al., 2000 x   x  Anx Tr Clinical Central Regulation Causal 
196 Yiend et al., 2008 x     Anx Exp Non clinical Central Regulation Descriptive 
197 Youngstedt, & Kripke, 2007 x         Anx Tr Non clinical Central Regulation Causal 
 
Table caption 
Table 1: 197 studies (in alphabetical order) included in our literature review and organized as 
a function of the main variables (Construct; Domain; Population; Manipulation; Direction of 
the Effect; Approach; see section 1.3 in the main text for exact definitions). All these studies 
were carefully selected based on specific and strict criteria (repeated measures design, test-
retest interval shorter than 24 hours; see section 1.2). 
Abbreviations:  
Other column: EAS (Emotion Assessment Scale; Carlson et al., 1989); HAM-A (Hamilton 
Anxiety and Depression Scale-Anxiety; Hamilton, 1959); ARQ (Arousal Rating 
Questionnaire; Edwards, Burt, & Lipp, 2010); HADS-A (Hospital Anxiety and Depression 
Scale-A; Zigmond & Snaith, 1983); SUDS (Subjective Units of Distress Scale; Wolpe, 1958 
& 1990); TESI (Tension and Effort Stress Inventory; Svebak et al., 1991); BAI (Beck 
Anxiety Inventory; Beck, Epstein, Brown, & Steer, 1988); MRF (Mental Readiness Form; 
Krane, 1994); SSSSS-S (Smith Somatic Stress Symptoms Scale-State; Smith, 1990); MSQ-R 
(Motivational State Questionnaire-revised form; see Rogers & Revelle 1998); MAACL-r 
(Multiple Affect Adjective Check List-Revised, "Today" Form; Zuckerman & Lubin, 1985). 
When no name is provided for the measurement in this column, a compound measure created 
ad hoc was reported in the study.  
Construct column: Anx = Anxiety; Aff = Affect 
Domain column: Exp = Experimental; Tr = Treatment 
Direction of Effect Column: Ind/Reg = Induction/Regulation  
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Figure 1: (a) Classification of studies (expressed in percentage) separately for each 
questionnaire (STAI, POMS, PANAS, and VAS) as a function of the Domain variable 
(Experimental, Treatment or Applied). (b) Classification of studies (expressed in percentage) 
as a function of the Population variable (Clinical vs. Non-clinical). (c) Classification of 
studies (expressed in percentage) as a function of the Approach variable (Causal vs. 
Descriptive). (d) A mapping of the studies using two orthogonal axes/variables (Domain vs. 
Population) suggests that the four instruments occupy non-overlapping mean positions, 
consistent with their use in different domains or contexts. For each instrument, the actual 
numerical value corresponds to the center of the ellipse. The horizontal axis codes the 
difference (in percentage) between Experimental and Treatment studies. Along this axis, a 
negative number indicates that the percentage of studies classified as Treatment for the given 
tool outnumbers the amount of studies classified as Experimental. Conversely, a positive 
number indicates an opposite effect (in favor of Experimental). The vertical axis codes the 
difference (in percentage) between Clinical and Non Clinical studies. A negative number 
indicates that the number of studies labeled as Non Clinical for the given tool outnumbers the 
amount of studies classified as Clinical. Conversely, a positive number indicates an opposite 
trend (in favor of Clinical).  
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Figure 2: (a) Classification of studies (expressed in percentage) separately for each 
questionnaire (STAI, POMS, PANAS, and VAS) as a function of the Manipulation variable 
(Central vs. Peripheral). (b) Classification of studies (expressed in percentage) as a function 
of the Direction of the effect variable (Induction, Regulation or Combined).  
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Supplementary material: Table 2 
Entry Measures Cronbach ‘s alpha Correlations Test-retest Reliability 
1 
STAI-S 
VAS 
 STAI-S VAS r = .58  
15 
STAI-S 
VAS 
STAI-S .55  
STAI-S r = .49 
VAS r = .82 
16 POMS POMS .93 to .95   
18 
STAI-S 
VAR 
STAI-S .92 STAI-S VAR r = .69 to .73 VAR r = .55 to .66 
30 
STAI-S  
PANAS 
 STAI-S PANAS r = .82  
46 STAI-S STAI-S .77 to .94   
59 PANAS PANAS .81 to .88   
73 
STAI-S 
VAS 
STAI-S .89 STAI-S VAS r = .52 to .55 VAS r = .59 to .71 
74 STAI-S STAI-S .85   
90 STAI-S STAI-S .93   
92 STAI-S STAI-S .90 to .96   
97 
STAI-S  
PANAS 
STAI-S .88 to.90 
PANAS .79 to .82 
  
100 
STAI-S 
POMS-BI 
 STAI-POMS-T(bipolar) r =-.81  
102 STAI-S STAI-S .87   
103 
STAI-S 
VAS 
 STAI-S VAS r = .53 to .68  
106 
STAI-S 
Mood Form 
STAI-S . 95 to .96 
Mood Form >.80 
  
113 
STAI-S 
POMS 
 
STAI-POMS-T r =.79 
STAI-POMS TMDS r =.78 
 
131 POMS (compound) POMSc .96  POMSc r = .74 
140 
STAI-S  
POMS 
STAI-S .86 to .94 
POMS .54 to .82 
  
145 
STAI-S 
VAS 
 STAI-S VAS r = .31 to .33  
146 
STAI-S(once) 
PANAS 
STAI-S .94 
PANAS .80 to .92 
  
156 
STAI-S (brief) 
PANAS 
STAI-S .87   
158 POMS POMS .70  (Split-half r = .73 to .78) 
161 STAI-S   STAI-S r = .42 
163 STAI-S STAI-S .94   
165 VAS (compound) VASc .86 to .95 VASc & Neuroticism r = .41 to .50  
168 
PANAS-X 
PANAS 
PANAS-X fear . 89 
PANAS .79 
  
181 
STAI-S 
PANAS (once) 
STAI-S .89 to .90 
PANAS .90 
  
184 
STAI-S 
PANAS (trait) 
STAI-S .90 
PANAS .84 
  
188 
STAI-S 
STAI-S (short) 
STAI-S (short) .83 STAI-S STAI-S (short) r = .95  
189 VAS   VAS r = .06 to .70 
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Table Caption 
Table 2: Comparative psychometric data across the four instruments, as could be retrieved in 
some of the studies (N=197) included in our review. Entry number corresponds to an 
arbitrary number used to sort the studies (see Table 1).  
Abbreviations:  
STAI-S (State-Trait Anxiety Inventory-State Form); POMS (Profile of Mood States); POMS-
BI (POMS-Bipolar form); POMS-T (POMS, Tension subscale); PANAS (Positive and 
Negative Affect Schedule); VAS (Visual Analog Scale); VAR (Verbal Anxiety Rating) 
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